Document:

SECURITIES
PURCHASE AGREEMENT

    

    This
Securities Purchase Agreement (this "Agreement") is dated as of October 27, 2005
between Global Axcess Corp., a Nevada corporation whose principal place of
business is located at 224 Ponte Vedra Park Drive, Ponte Vedra Beach, Florida
32802 (the "Company"), and the Purchaser(s) listed on Schedule A attached hereto
(including its successors and assigns, the "Purchasers").

    

    WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to
Section 4(2) of the Securities Act of 1933, as amended (the "Securities Act")
and Rule 506 promulgated thereunder, the Company desires to issue and sell to
the Purchasers, and each Purchaser desires to purchase from the Company,
securities of the Company as more fully described in this Agreement.

    

    NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement,
and for other good and valuable consideration the receipt and adequacy of which
are hereby acknowledged, the Company and the Purchaser agree as
follows:

    

    ARTICLE
I.

    DEFINITIONS

    

    1.1           Definitions.
In addition to the terms defined elsewhere in this Agreement: (a) capitalized
terms that are not otherwise defined herein have the meanings given to such
terms in the Notes (as defined herein), and (b) the following terms have the
meanings indicated in this Section 1.1:

    

    "Action"
shall have the meaning ascribed to such term in Section 3.1(j).

    

    "Affiliate"
means any Person that, directly or indirectly through one or more
intermediaries, controls or is controlled by or is under common control with a
Person, as such terms are used in and construed under Rule 144 under the
Securities Act. With respect to a Purchaser, any investment fund or managed
account that is managed on a discretionary basis by the same investment manager
as the Purchaser will be deemed to be an Affiliate of the
Purchaser.

    

    "Closing"
means the closing of the purchase and sale of the Securities pursuant to Section
2.1.

    

    "Closing
Date" means the Trading Day when all of the Transaction Documents have been
executed and delivered by the applicable parties thereto, and all conditions
precedent to (i) the Purchasers' obligations to pay the Subscription Amount and
(ii) the Company's obligations to deliver the Securities have been satisfied or
waived.

    

    "Commission"
means the Securities and Exchange Commission.

    

    "Common
Stock" means the common stock of the Company, par value $0.001, and any
securities into which such common stock shall hereinafter have been reclassified
into.

    

    "Common
Stock Equivalents" means any securities of the Company or the Subsidiaries which
would entitle the holder thereof to acquire at any time Common Stock, including
without limitation, any debt, preferred stock, rights, options, warrants or
other instrument that is at any time convertible into or exchangeable for, or
otherwise entitles the holder thereof to receive, Common Stock.

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    "Company
Counsel" means Sichenzia Ross Friedman Ference LLP. "Conversion Price" shall
have the meaning ascribed to such term in the Note.

    

    "Disclosure
Schedules" shall have the meaning ascribed to such term in Section 3.1
hereof.

    

    "Effective
Date" means the date that the initial Registration Statement filed by the
Company pursuant to the Registration Rights Agreement is first declared
effective by the Commission.

    

    "Exchange
Act" means the Securities Exchange Act of 1934, as amended.

    

    "Exempt
Issuance" means the issuance of (a) shares of Common Stock or options to
employees, officers or directors of the Company pursuant to any stock or option
plan duly adopted by a majority of the non-employee members of the Board of
Directors of the Company or a majority of the members of a committee of
non-employee directors established for such purpose, (b) securities upon the
exercise of or conversion of any securities issued hereunder, convertible
securities, options or warrants issued and outstanding on the date of this
Agreement, provided that such securities have not been amended since the date of
this Agreement to increase the number of such securities or (c) shares of common
stock issued in connection with the offering of up to $2,000,000 in shares of
common stock at $1.25 per share (the "Current Offering").

    

    "GAAP"
shall have the meaning ascribed to such term in Section 3.1(h)
hereof.

    

    "Liens"
means a lien, charge, security interest, encumbrance, right of first refusal,
preemptive right or other restriction.

    

    "Material
Adverse Effect" shall have the meaning assigned to such term in Section 3.1(b)
hereof.

    

    "Material
Permits" shall have the meaning ascribed to such term in Section
3.1(m).

    

    "Notes"
means the 9% Senior Subordinated Secured Convertible Notes due, subject to the
terms therein, three years from its date of issuance, issued by the Company to
the Purchasers hereunder, in the form of Exhibit A.

    

    "Person"
means an individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability company, joint
stock company, government (or an agency or subdivision thereof) or other entity
of any kind.

    

    "Proceeding"
means an action, claim, suit, investigation or proceeding (including, without
limitation, an investigation or partial proceeding, such as a deposition),
whether commenced or threatened.

    

    "Registration
Rights Agreement" means the Registration Rights Agreement, dated the date
hereof, among the Company and the Purchaser, in the form of Exhibit C attached
hereto.

    
      
         

      

      
        2 of
27

        
          

        

      

      
         

      

    

    

    "Registration
Statement" means a registration statement meeting the requirements set forth in
the Registration Rights Agreement and covering the resale of the Underlying
Shares by the Purchaser as provided for in the Registration Rights
Agreement.

    

    "Required
Approvals" shall have the meaning ascribed to such term in Section
3.1(e).

    

    "Required
Minimum" means, as of any date, the maximum aggregate number of shares of Common
Stock then issued or potentially issuable in the future pursuant to the
Transaction Documents, including any Underlying Shares issuable upon exercise or
conversion in full of all Warrants and Notes (including Underlying Shares
issuable as payment of interest), ignoring any conversion or exercise limits set
forth therein, and assuming that the Conversion Price is at all times on and
after the date of determination 75% of the then Conversion Price on the Trading
Day immediately prior to the date of determination.

    

    "Rule
144" means Rule 144 promulgated by the Commission pursuant to the Securities
Act, as such Rule may be amended from time to time, or any similar rule or
regulation hereafter adopted by the Commission having substantially the same
effect as such Rule.

    

    "SEC
Reports" shall have the meaning ascribed to such term in Section 3.1(h)
hereof.

    

    "Securities"
means the Notes, the Warrants and the Underlying Shares.

    

    "Securities
Act" means the Securities Act of 1933, as amended.

    

    "Security
Agreement" means the Security Agreement, dated the date hereof, between the
Company and the Purchaser, in the form of Exhibit D attached
hereto.

    

    "Security
Documents" means the Security Agreement, the Subsidiary Guarantee(s) and any
other documents and filings required thereunder in order to grant the Purchasers
a perfected security interest in all of the assets of the Company, including all
UCC-1 filing receipts.

    

    "Subscription
Amount" means, as to the Purchasers, the aggregate amount to be paid for Notes
and Warrants purchased hereunder as specified below the Purchasers' name on the
signature page of this Agreement and next to the heading "Subscription Amount",
in United States Dollars and in immediately available funds.

    

    "Subsidiary"
means any subsidiary of the Company as set forth on Schedule
3.1(a).

    

    "Subsidiary
Guarantee(s)" means the Subsidiary Guarantee(s), dated the date hereof, among
each of the Subsidiaries and the Purchaser, in the form of Exhibit E attached
hereto.

    

    "Trading
Day" means a day on which the Common Stock is traded on a Trading
Market.

    

    "Trading
Market" means the following markets or exchanges on which the Common Stock is
listed or quoted for trading on the date in question: the Nasdaq SmallCap
Market, the American Stock Exchange, the New York Stock Exchange, the Nasdaq
National Market or the OTC Bulletin Board.

    

    "Transaction
Documents" means this Agreement, the Notes, the Warrants, the Security
Agreement, the Subsidiary Guarantee(s), the Registration Rights Agreement and
any other documents or agreements executed in connection with the transactions
contemplated hereunder.

    
      
         

      

      
        3 of
27

        
          

        

      

      
         

      

    

    

    "Underlying
Shares" means the shares of Common Stock issuable upon conversion of the Notes
and the Warrant Shares,

    

    "VWAP"
means, for any date, the price determined by the first of the following clauses
that applies: (a) if the Common Stock is then listed or quoted on a Trading
Market, the daily volume weighted average price of the Common Stock for such
date (or the nearest preceding date) on the primary Trading Market on which the
Common Stock is then listed or quoted as reported by Bloomberg Financial L.P.
(based on a Trading Day from 9:30 a.m. EST to 4:02 p.m. Eastern Time) using the
VAP function; (b) if the Common Stock is not then listed or quoted on the
Trading Market and if prices for the Common Stock are then reported in the "Pink
Sheets" published by the Pink Sheets, LLC (or a similar organization or agency
succeeding to its functions of reporting prices), the most recent bid price per
share of the Common Stock so reported; or (c) in all other cases, the fair
market value of a share of Common Stock as determined by a nationally
recognized-independent appraiser selected in good faith by Purchaser holding a
majority of the principal amount of Notes then outstanding.

    

    "Warrants"
means collectively the Common Stock purchase warrants, in the form of Exhibit B
delivered to the Purchasers at the Closing in accordance with Section 2.2(a)
hereof, which Warrants shall be exercisable immediately and have a term of
exercise equal to five years.

    

    "Warrant
Shares" means the shares of Common Stock issuable upon exercise of the
Warrants.

    

    ARTICLE
II.

    PURCHASE
AND SALE

    

    2.1           Closing.
On the Closing Date, upon the terms and subject to the conditions set forth
herein, concurrent with the execution and delivery of this Agreement by the
parties hereto, the Company agrees to sell, and the Purchasers agree to
purchase, $3,500,000 aggregate principal amount of the Notes, secured by a
second priority lien, more fully described in the Security Agreement, on all
assets of the Company (including a pledge of the shares of the Company's
Subsidiaries).

    

    Each
Purchaser shall deliver to the Company via wire transfer immediately available
funds equal to its Subscription Amount and the Company shall deliver to each
Purchaser its Note and Warrants as determined pursuant to Section 2.2(a), and
the other items set forth in Section 2.2 issuable at the Closing. Upon
satisfaction of the conditions set forth in Section 2.2, the Closing shall occur
at the offices of the Company, or such other location as the parties shall
mutually agree.

    

    
      	
               
      

            	
              2.2

            	
              Deliveries.

            

    

    

    
      	
               
      

            	
              a)

            	
              On
      the Closing Date, the Company shall deliver to the counsel for the
      Purchasers with respect to the Purchasers the
  following:

            

    

    

    
      	
               
      

            	
              (i)

            	
              this
      Agreement duly executed by the
Company;

            

    

    

    
      	
               
      

            	
              (ii)

            	
              a
      Note with a principal amount equal to each Purchaser's Subscription
      Amount, registered in the name of such
  Purchaser;

            

    

    

    
      	
               
      

            	
              (iii)

            	
              Warrants
      registered in the name of the Purchasers to purchase 910,000 shares of
      Common Stock of the Company with an exercise price of $1.75 per
      share;

            

    

    
      
         

      

      
        4 of
27

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              (iv)

            	
              the
      Registration Rights Agreement duly executed by the
  Company;

            

    

    

    
      	
               
      

            	
              (v)

            	
              the
      Security Agreement, duly executed by the Company and the Subsidiaries,
      along with all the Security
Documents;

            

    

    

    
      	
               
      

            	
              (vi)

            	
              the
      Subsidiary Guarantee(s), duly executed by the Subsidiaries;
      and

            

    

    

    
      	
               
      

            	
              (vii)

            	
              a
      legal opinion of Company Counsel.

            

    

    

    
      	
               
      

            	
              b)

            	
              On
      the Closing Date, each Purchaser shall deliver or cause to be delivered to
      Company Counsel the following:

            

    

    

    
      	
               
      

            	
              (i)

            	
              this
      Agreement duly executed by such
Purchaser;

            

    

    

    
      	
               
      

            	
              (ii)

            	
              the
      Purchaser's Subscription Amount by wire transfer to the account of the
      Company;

            

    

    

    
      	
               
      

            	
              (iii)

            	
              the
      Registration Rights Agreement duly executed by such Purchaser;
      and

            

    

    

    
      	
               
      

            	
              (iv)

            	
              the
      Security Agreement, duly executed by such
  Purchaser.

            

    

    

    
      	
               
      

            	
              2.3

            	
              Closing
      Conditions.

            

    

    

    
      	
               
      

            	
              a)

            	
              The
      obligations of the Company hereunder in connection with the Closing are
      subject to the following conditions being
met:

            

    

    

    
      	
               
      

            	
              (i)

            	
              the
      accuracy in all material respects when made and on the Closing Date of the
      representations and warranties of the Purchasers contained
      herein;

            

    

    

    
      	
               
      

            	
              (ii)

            	
              all
      obligations, covenants and agreements of each Purchaser required to be
      performed at or prior to the Closing Date shall have been performed;
      and

            

    

    

    
      	
               
      

            	
              (iii)

            	
              the
      delivery by each Purchaser of the items set forth in Section 2.2(b) of
      this Agreement.

            

    

    

    
      	
               
      

            	
              b)

            	
              The
      respective obligations of each Purchaser hereunder in connection with the
      Closing are subject to the following conditions being
  met:

            

    

    

    
      	
               
      

            	
              (i)

            	
              the
      accuracy in all material respects on the Closing Date of the
      representations and warranties of the Company contained
      herein;

            

    

    

    
      	
               
      

            	
              (ii)

            	
              all
      obligations, covenants and agreements of the Company required to be
      performed at or prior to the Closing Date shall have been
      performed;

            

    

    

    
      	
               
      

            	
              (iii)

            	
              such
      Purchaser shall be satisfied with the results of its due diligence
      investigation of the Company;

            

    

    
      
         

      

      
        5 of
27

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              (iv)

            	
              such
      Purchaser shall be satisfied with the Company's current and projected uses
      of cash;

            

    

    

    
      	
               
      

            	
              (v)

            	
              the
      delivery by the Company of the items set forth in Section 2.2(a) of this
      Agreement;

            

    

    

    
      	
               
      

            	
              (vi)

            	
              all
      obligations of the Company shall be subordinated in right of payment to
      the Notes (other than those in favor of the Senior Lender (as herein
      defined)) which shall not exceed $5.0
million;

            

    

    

    
      	
               
      

            	
              (vii)

            	
              such
      Purchaser being satisfied with the terms of the acquisition of the ATM
      portfolio and any equity investments in the
  Company;

            

    

    

    
      	
               
      

            	
              (viii)

            	
              completion
      of the acquisition of the ATM
portfolio;

            

    

    

    
      	
               
      

            	
              (ix)

            	
              there
      shall have been no Material Adverse Effect with respect to the Company and
      its Subsidiaries since the date hereof;
and

            

    

    

    
      	
               
      

            	
              (x)

            	
              No
      banking moratorium have been declared either by the United States or New
      York State authorities nor shall there have occurred any material outbreak
      or escalation of hostilities or other national or international calamity
      of such magnitude in its effect on, or any material adverse change in, any
      financial markets which, in each case, in the reasonable judgment of such
      Purchaser, makes it impracticable or inadvisable to purchase the Notes at
      the Closing.

            

    

    

    ARTICLE
III.

    REPRESENTATIONS
AND WARRANTIES

    

    3.1          Representations
and Warranties of the Company. Except as set forth in the Disclosure Schedule
which Disclosure Schedule shall be deemed a part hereof, the Company hereby
makes the representations and warranties set forth below to the
Purchaser.

    

    (a)  
Subsidiaries. All of the direct and indirect subsidiaries of the Company are set
forth in the Disclosure Schedule. The Company owns, directly or indirectly, all
of the capital stock or other equity interests of each Subsidiary free and clear
of any Liens (other than the Liens in favor of Wachovia Bank (the "Senior
Lender"), and all the issued and outstanding shares of capital stock of each
Subsidiary are validly issued and are fully paid, non-assessable and free of
preemptive and similar rights to subscribe for or purchase
securities.

    

    (b) 
 Organization and Qualification. Each of the Company and the Subsidiaries
is an entity duly incorporated or otherwise organized, validly existing and in
good standing under the laws of the jurisdiction of its incorporation or
organization (as applicable), with the requisite power and authority to own and
use its properties and assets and to carry on its business as currently
conducted. Neither the Company nor any Subsidiary is in violation or default of
any of the provisions of its respective certificate or articles of
incorporation, bylaws or other organizational or charter documents. Each of the
Company and the Subsidiaries is duly qualified to conduct business and is in
good standing as a foreign corporation or other entity in each jurisdiction in
which the nature of the business conducted or property owned by it makes such
qualification necessary, except where the failure to be so qualified or in good
standing, as the case may be, could not have or reasonably be expected to result
in (i) a material adverse effect on the legality, validity or enforceability of
any Transaction Document, (ii) a material adverse effect on the results of
operations, assets, business, prospects or financial condition of the Company
and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on
the Company's ability to perform in any material respect on a timely basis its
obligations under any Transaction Document (any of (i), (ii) or (iii), a
"Material Adverse Effect") and no Proceeding has been instituted in any such
jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or
curtail such power and authority or qualification.

    
      
         

      

      
        6 of
27

        
          

        

      

      
         

      

    

    

    (c) 
 Authorization; Enforcement. The Company has the requisite corporate power
and authority to enter into and to consummate the transactions contemplated by
each of the Transaction Documents and otherwise to carry out its obligations
thereunder. The execution and delivery of each of the Transaction Documents by
the Company and the consummation by it of the transactions contemplated thereby
have been duly authorized by all necessary action on the part of the Company and
no further action is required by the Company in connection therewith other than
in connection with the Required Approvals. Each Transaction Document has been
(or upon delivery will have been) duly executed by the Company and, when
delivered in accordance with the terms hereof, will constitute the valid and
binding obligation of the Company enforceable against the Company in accordance
with its terms except (i) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium and other laws of general application affecting
enforcement of creditors' rights generally and (ii) as limited by laws relating
to the availability of specific performance, injunctive relief or other
equitable remedies.

    

    (d)  
No Conflicts. The execution, delivery and performance of the Transaction
Documents by the Company and the consummation by the Company of the other
transactions contemplated thereby do not and will not: (i) conflict with or
violate any provision of the Company's or any Subsidiary's certificate or
articles of incorporation, bylaws or other organizational or charter documents,
or (ii) conflict with, or constitute a default (or an event that with notice or
lapse of time or both would become a default) under, result in the creation of
any Lien upon any of the properties or assets of the Company or any Subsidiary,
or give to others any rights of termination, amendment, acceleration or
cancellation (with or without notice, lapse of time or both) of, any agreement,
credit facility, debt or other instrument (evidencing a Company or Subsidiary
debt or otherwise) or other understanding to which the Company or any Subsidiary
is a party or by which any property or asset of the Company or any Subsidiary is
bound or affected, or (iii) subject to the Required Approvals, conflict with or
result in a violation of any law, rule, regulation, order, judgment, injunction,
decree or other restriction of any court or governmental authority to which the
Company or a Subsidiary is subject (including federal and state securities laws
and regulations), or by which any property or asset of the Company or a
Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material
Adverse Effect.

    

    (e) 
 Filings, Consents and Approvals. Except as set forth in the Disclosure
Schedule, the Company is not required to obtain any consent, waiver,
authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other
governmental authority or other Person in connection with the execution,
delivery and performance by the Company of the Transaction
Documents.

    

    (f) 
 Issuance of the Securities. The Securities are duly authorized and, when
issued and paid for in accordance with the applicable Transaction Documents,
will be duly and validly issued, fully paid and nonassessable, free and clear of
all Liens imposed by the Company other than restrictions on transfer provided
for in the Transaction Documents. The Underlying Shares, when issued in
accordance with the terms of the Transaction Documents, will be validly issued,
fully paid and nonassessable, free and clear of all Liens imposed by the
Company. The Company has reserved from its duly authorized capital stock a
number of shares of Common Stock for issuance of the Underlying Shares at least
equal to the Required Minimum on the date hereof. The Company has not, and to
the knowledge of the Company, no Affiliate of the Company has sold, offered for
sale or solicited offers to buy or otherwise negotiated in respect of any
security (as defined in Section 2 of the Securities Act) that would be
integrated with the offer or sale of the Securities in a manner that would
require the registration under the Securities Act of the sale of the Securities
to the Purchaser, or that would be integrated with the offer or sale of the
Securities for purposes of the rules and regulations of any Trading
Market.

    
      
         

      

      
        7 of
27

        
          

        

      

      
         

      

    

    

    (g)  Capitalization.
The capitalization of the Company is as set forth in the Description of
Securities section of the Disclosure Schedule. Other than as set forth on the
Disclosure Schedule, the Company and the Subsidiaries have no indebtedness. The
Company has not issued any capital stock since ______________. No Person has any
right of first refusal, preemptive right, right of participation, or any similar
right to participate in the transactions contemplated by the Transaction
Documents. Except as set forth in the Disclosure Schedule, as a result of the
purchase and sale of the Securities, there are no outstanding options, warrants,
script rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities, rights or obligations convertible into or
exchangeable for, or giving any Person any right to subscribe for or acquire,
any shares of Common Stock, or contracts, commitments, understandings or
arrangements by which the Company or any Subsidiary is or may become bound to
issue additional shares of Common Stock, or securities or rights convertible or
exchangeable into shares of Common Stock. The issuance and sale of the
Securities will not obligate the Company to issue shares of Common Stock or
other securities to any Person (other than the Purchaser) and will not result in
a right of any holder of Company securities to adjust the exercise, conversion,
exchange or reset price under such securities. All of the outstanding shares of
capital stock of the Company are validly issued, fully paid and nonassessable,
have been issued in compliance with all federal and state securities laws, and
none of such outstanding shares was issued in violation of any preemptive rights
or similar rights to subscribe for or purchase securities. No further approval
or authorization of any stockholder, the Board of Directors of the Company or
others is required for the issuance and sale of the Securities. There are no
stockholders agreements, voting agreements or other similar agreements with
respect to the Company's capital stock to which the Company is a party or, to
the knowledge of the Company, between or among any of the Company's
stockholders.

    

    (h) 
 SEC Reports; Financial Statements. The Company has filed all reports
required to be filed by it under the Securities Act and the Exchange Act,
including pursuant to Section 13(a) or 15(d) thereof, for the two years
preceding the date hereof (or such shorter period as the Company was required by
law to file such material) (the foregoing materials, including the exhibits
thereto, being collectively referred to herein as the "SEC Reports") on
______________ a timely basis or has received a valid extension of such time of
filing and has filed any such SEC Reports prior to the expiration of any such
extension. As of their respective dates, the SEC Reports complied in all
material respects with the requirements of the Securities Act and the Exchange
Act and the rules and regulations of the Commission promulgated thereunder, and
none of the SEC Reports, when filed, contained any untrue statement of a
material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. The financial
statements of the Company comply in all material respects with applicable
accounting requirements and the rules and regulations of the Commission with
respect thereto as in effect at the time of filing. Such financial statements
have been prepared in accordance with United States generally accepted
accounting principles applied on a consistent basis during the periods involved
("GAAP"), except as may be otherwise specified in such financial —— statements
or the notes thereto and except that unaudited financial statements may not
contain all footnotes required by GAAP, and fairly present in all material
respects the financial position of the Company and its consolidated subsidiaries
as of and for the dates thereof and the results of operations and cash flows for
the periods then ended, subject, in the case of unaudited statements, to normal,
immaterial, year-end audit adjustments.

    
      
         

      

      
        8 of
27

        
          

        

      

      
         

      

    

    

    (i)  
 Material Changes. Since the date of the latest audited financial
statements, (i) there has been no event, occurrence or development that has had
or that could reasonably be expected to result in a Material Adverse Effect,
(ii) the Company has not incurred any liabilities (contingent or otherwise)
other than (A) trade payables and accrued expenses incurred in the ordinary
course of business consistent with past practice and (B) liabilities not
required to be reflected in the Company's financial statements pursuant to GAAP
or required to be disclosed in filings made with the Commission, (iii) the
Company has not altered its method of accounting, (iv) the Company has not
declared or made any dividend or distribution of cash or other property to its
stockholders or purchased, redeemed or made any agreements to purchase or redeem
any shares of its capital stock and (v) the Company has not issued any equity
securities to any officer, director or Affiliate, except pursuant to existing
Company stock option plans. The Company does not have pending before the
Commission any request for confidential treatment of information.

    

    (j)  
 Litigation. Other than as set forth in the Disclosure Schedule under the
caption "Legal Proceedings," there is no action, suit, inquiry, notice of
violation, proceeding or investigation pending or, to the knowledge of the
Company, threatened against or affecting the Company, any Subsidiary or any of
their respective properties before or by any court, arbitrator, governmental or
administrative agency or regulatory authority (federal, state, county, local or
foreign) (collectively, an "Action") which (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or
the Securities or (ii) could, if there were an unfavorable decision, have or
reasonably be expected to result in a Material Adverse Effect. Neither the
Company nor any Subsidiary, nor any director or officer thereof, is or has been
the subject of any Action involving a claim of violation of or liability under
federal or state securities laws or a claim of breach of fiduciary duty. There
has not been, and to the knowledge of the Company, there is not pending or
contemplated, any investigation by the Commission involving the Company or any
current or former director or officer of the Company. The Commission has not
issued any stop order or other order suspending the effectiveness of any
registration statement filed by the Company or any Subsidiary under the Exchange
Act or the Securities Act.

    

    (k) 
 Labor Relations. No material labor dispute exists or, to the knowledge of
the Company, is imminent with respect to any of the employees of the Company
which could reasonably be expected to result in a Material Adverse
Effect.

    

    (l) 
 Compliance. Neither the Company nor any Subsidiary (i) is in default under
or in violation of (and no event has occurred that has not been waived that,
with notice or lapse of time or both, would result in a default by the Company
or any Subsidiary under), nor has the Company or any Subsidiary received notice
of a claim that it is in default under or that it is in violation of, any
indenture, loan or credit agreement or any other agreement or instrument to
which it is a party or by which it or any of its properties is bound (whether or
not such default or violation has been waived), (ii) is in violation of any
order of any court, arbitrator or governmental body, or (iii) is or has been in
violation of any statute, rule or regulation of any governmental authority,
including without limitation all foreign, federal, state and local laws
applicable to its business except in each case as could not have a Material
Adverse Effect.

    
      
         

      

      
        9 of
27

        
          

        

      

      
         

      

    

    

    (m)
 Regulatory Permits. The Company and the Subsidiaries possess all
certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their
respective businesses, except where the failure to possess such permits could
not have or reasonably be expected to result in a Material Adverse Effect
("Material Permits"), and neither the Company nor any Subsidiary has received
any notice of proceedings relating to the revocation or modification of any
Material Permit.

    

    (n) 
Title to Assets. The Company and the Subsidiaries have good and marketable title
in fee simple to all real property owned by them that is material to the
business of the Company and the Subsidiaries and good and marketable title in
all personal property owned by them that is material to the business of the
Company and the Subsidiaries, in each case free and clear of all Liens, except
for (i) Liens as do not materially affect the value of such property and do not
materially interfere with the use made and proposed to be made of such property
by the Company and the Subsidiaries, (ii) Liens for the payment of federal,
state or other taxes, the payment of which is neither delinquent nor subject to
penalties and (iii) Liens held by the Senior Lender and any capital leases held
on ATMs and other equipment. Any real property and facilities held under lease
by the Company and the Subsidiaries are held by them under valid, subsisting and
enforceable leases of which the Company and the Subsidiaries are in
compliance.

    

    (o)  
Patents and Trademarks. The Company and the Subsidiaries have, or have rights to
use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, copyrights, licenses and other similar rights
necessary or material for use in connection with their respective businesses and
which the failure to so have could have a Material Adverse Effect (collectively,
the "Intellectual Property Rights"). Neither the Company nor any Subsidiary has
received a written notice that the Intellectual Property Rights used by the
Company or any Subsidiary violates or infringes upon the rights of any Person.
To the knowledge of the Company, all such Intellectual Property Rights are
enforceable and there is no existing infringement by another Person of any of
the Intellectual Property Rights of others.

    

    (p)  
Insurance. The Company and the Subsidiaries are insured by insurers of
recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and
the Subsidiaries are engaged, at least equal to the aggregate Subscription
Amount. To the best of Company's knowledge, such insurance contracts and
policies are accurate and complete. Neither the Company nor any Subsidiary has
any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from
similar insurers as may be necessary to continue its business without a
significant increase in cost.

    

    (q) 
 Transactions With Affiliates and Employees. None of the officers or
directors of the Company and, to the knowledge of the Company, none of the
employees of the Company is presently a party to any transaction with the
Company or any Subsidiary (other than for services as employees, officers and
directors), including any contract, agreement or other arrangement providing for
the furnishing of services to or by, providing for rental of real or personal
property to or from, or otherwise requiring payments to or from any officer,
director or such employee or, to the knowledge of the Company, any entity in
which any officer, director, or any such employee has a substantial interest or
is an officer, director, trustee or partner, in each case in excess of $50,000
other than (i) for payment of salary or consulting fees for services rendered,
(ii) reimbursement for expenses incurred on behalf of the Company and (iii) for
other employee benefits, including stock option agreements under any stock
option plan of the Company.

    
      
         

      

      
        10 of
27

        
          

        

      

      
         

      

    

    

    (r)  
Sarbanes-Oxley; Internal Accounting Controls. The Company is in material
compliance with all provisions of the Sarbanes-Oxley Act of 2002 which are
applicable to it as of the Closing Date. The Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide
reasonable assurance that (i) transactions are executed in accordance with
management's general or specific authorizations, (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (iii) access to assets is permitted
only in accordance with management's general or specific authorization, and (iv)
the recorded accountability for assets is compared with the existing assets at
reasonable intervals and appropriate action is taken with respect to any
differences. The Company has established disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and
designed such disclosure controls and procedures to ensure that material
information relating to the Company, including its Subsidiaries, is made known
to the certifying officers by others within those entities, particularly during
the period in which the Company's most recently filed periodic report under the
Exchange Act, as the case may be, is being prepared. The Company's certifying
officers have evaluated the effectiveness of the Company's controls and
procedures as of the date prior to the filing date of the most recently filed
periodic report under the Exchange Act (such date, the "Evaluation Date"). The
Company presented in its most recently filed periodic report under the Exchange
Act the conclusions of the certifying officers about the effectiveness of the
disclosure controls and procedures based on their evaluations as of the
Evaluation Date. Since the Evaluation Date, there have been no significant
changes in the Company's internal controls (as such term is defined in Item
307(b) of Regulation S-K under the Exchange Act) or, to the Company's knowledge,
in other factors that could significantly affect the Company's internal
controls.

    

    (s)  
Certain Fees. Except as set forth in the Disclosure Schedule under the caption
"Recent Sales of Unregistered Securities; Use of Proceeds from Registered
Securities," no brokerage or finder's fees or commissions are or will be payable
by the Company to any broker, financial advisor or consultant, finder, placement
agent, investment banker, bank or other Person with respect to the transactions
contemplated by this Agreement. The Purchaser shall have no obligation with
respect to any fees or with respect to any claims made by or on behalf of other
Persons for fees of a type contemplated in this Section that may be due in
connection with the transactions contemplated by this Agreement.

    

    (t) 
 Private Placement. Assuming the accuracy of the Purchasers representations
and warranties set forth in Section 3.2, no registration under the Securities
Act is required for the offer and sale of the Securities by the Company to the
Purchaser as contemplated hereby. The issuance and sale of the Securities
hereunder does not contravene the rules and regulations of the Trading
Market.

    

    (u) 
 Investment Company. The Company is not, and is not an Affiliate of, and
immediately after receipt of payment for the Securities, will not be or be an
Affiliate of, an "investment company" within the meaning of the Investment
Company Act of 1940, as amended. The Company shall conduct its business in a
manner so that it will not become subject to the Investment Company
Act.

    
      
         

      

      
        11 of
27

        
          

        

      

      
         

      

    

    

    (v) 
 Registration Rights. Except as contemplated by the transactions hereunder
and as set forth in the Disclosure Schedule, no Person has any right to cause
the Company to effect the registration under the Securities Act of any
securities of the Company.

    

    (w)
 Reserved.

    

    (x)  
Application of Takeover Protections. The Company and its Board of Directors have
taken all necessary action, if any, in order to render inapplicable any control
share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or other similar anti-takeover provision under the
Company's Certificate of Incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the
Purchasers as a result of the Purchasers and the Company fulfilling their
obligations or exercising their rights under the Transaction Documents,
including without limitation as a result of the Company's issuance of the
Securities and the Purchasers' ownership of the Securities.

    

    (y) 
 Disclosure. The Company confirms that neither it nor any other Person
acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that constitutes or might constitute material,
nonpublic information. The Company understands and confirms that each Purchaser
will rely on the foregoing representations and covenants in effecting
transactions in securities of the Company. All disclosure provided to the
Purchasers regarding the Company, its business and the transactions contemplated
hereby, including the Disclosure Schedules to this Agreement, furnished by or on
behalf of the Company with respect to the representations and warranties made
herein are true and correct with respect to such representations and warranties
and do not contain any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements made therein, in light
of the circumstances under which they were made, not misleading. The Company
acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2 hereof.

    

    (z) 
 No Integrated Offering. Assuming the accuracy of the Purchaser's
representations and warranties set forth in Section 3.2, neither the Company,
nor any of its affiliates, nor any Person acting on its or their behalf has,
directly or indirectly, made any offers or sales of any security or solicited
any offers to buy any security, under circumstances that would cause this
offering of the Securities to be integrated with prior offerings by the Company
for purposes of the Securities Act or any applicable shareholder approval
provisions, including, without limitation, under the rules and regulations of
any exchange or automated quotation system on which any of the securities of the
Company are listed or designated.

    

    (aa)
Solvency. Based on the financial condition of the Company as of the Closing Date
after giving effect to the receipt by the Company of the proceeds from the sale
of the Securities hereunder, (i) the Company's fair saleable value of its assets
exceeds the amount that will be required to be paid on or in respect of the
Company's existing debts and other liabilities (including known contingent
liabilities) as they mature; (ii) the Company's assets do not constitute
unreasonably small capital to carry on its business for the current fiscal year
as now conducted and as proposed to be conducted including its capital needs
taking into account the particular capital requirements of the business
conducted by the Company, and projected capital requirements and capital
availability thereof; and (iii) the current cash flow of the Company, together
with the proceeds the Company would receive, were it to liquidate all of its
assets, after taking into account all anticipated uses of the cash, would be
sufficient to pay all amounts on or in respect of its debt when such amounts are
required to be paid. The Company does not intend to incur debts beyond its
ability to pay such debts as they mature (taking into account the timing and
amounts of cash to be payable on or in respect of its debt). The Company has no
knowledge of any facts or circumstances which lead it to believe that it will
file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. The financial
statements of the Company set forth as of the dates thereof all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for
which the Company or any Subsidiary has commitments. For the purposes of this
Agreement, "Indebtedness" shall mean (a) any liabilities for borrowed money or
amounts owed in excess of $50,000 (other than trade accounts payable incurred in
the ordinary course of business), (b) all guaranties, endorsements and other
contingent obligations in respect of Indebtedness of others, whether or not the
same are or should be reflected in the Company's balance sheet (or the notes
thereto), except guaranties by endorsement of negotiable instruments for deposit
or collection or similar transactions in the ordinary course of business; and
(c) the present value of any lease payments in excess of $50,000 due under
leases required to be capitalized in accordance with GAAP. Neither the Company
nor any Subsidiary is in default with respect to any
Indebtedness.

    
      
         

      

      
        12 of
27

        
          

        

      

      
         

      

    

    

    (bb) Tax
Status. Except for matters that would not, individually or in the aggregate,
have or reasonably be expected to result in a Material Adverse Effect, the
Company and each Subsidiary has filed all necessary federal, state and foreign
income and franchise tax returns and has paid or accrued all taxes shown as due
thereon, and the Company has no knowledge of a tax deficiency which has been
asserted or threatened against the Company or any Subsidiary.

    

    (cc) No
General Solicitation. Neither the Company nor any person acting on behalf of the
Company has offered or sold any of the Securities by any form of general
solicitation or general advertising. The Company has offered the Securities for
sale only to the Purchaser and certain other "accredited investors" within the
meaning of Rule 501 under the Securities Act.

    

    (dd)
Foreign Corrupt Practices. Neither the Company, nor to the knowledge of the
Company, any agent or other person acting on behalf of the Company, has (i)
directly or indirectly, used any corrupt funds for unlawful contributions,
gifts, entertainment or other unlawful expenses related to foreign or domestic
political activity, (ii) made any unlawful payment to foreign or domestic
government officials or employees or to any foreign or domestic political
parties or campaigns from corporate funds, (iii) failed to disclose fully any
contribution made by the Company (or made by any person acting on its behalf of
which the Company is aware) which is in violation of law, or (iv) violated in
any material respect any provision of the Foreign Corrupt Practices Act of 1977,
as amended

    

    (ee)
Accountants. The Company's accountants are Kirkland, Russ, Murphy & Tapp,
LLC. To the Company's knowledge, such accountants, who the Company expects will
express their opinion with respect to the financial statements for the year
ending December 31, 2005, are a registered public accounting firm as required by
the Securities Act.

    

    (ff)
Seniority. As of the Closing Date, no indebtedness or other equity of the
Company is senior to, or pari passu with, the Notes in right of payment, whether
with respect to interest or upon liquidation or dissolution, or otherwise, other
than indebtedness in favor of the Senior Lender, indebtedness secured by
purchase money security interests (which is senior only as to underlying assets
covered thereby) and capital lease obligations (which is senior only as to the
property covered thereby).

    
      
         

      

      
        13 of
27

        
          

        

      

      
         

      

    

    

    (gg) No
Disagreements with Accountants and Lawyers. There are no disagreements of any
kind presently existing, or reasonably anticipated by the Company to arise,
between the accountants and lawyers formerly or presently employed by the
Company and the Company is current with respect to any fees owed to its
accountants and lawyers. By making this representation the Company does not, in
any manner, waive the attorney/client privilege or the confidentiality of the
communications between the Company and its lawyers.

    

    (hh)
Acknowledgment Regarding Purchaser's Purchase of Securities. The Company
acknowledges and agrees that each of the Purchaser is acting solely in the
capacity of an arm's length purchaser with respect to the Transaction Documents
and the transactions contemplated hereby. The Company further acknowledges that
no Purchaser is acting as a financial advisor or fiduciary of the Company (or in
any similar capacity) with respect to this Agreement and the transactions
contemplated hereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with this Agreement and the
transactions contemplated hereby is merely incidental to the Purchaser's
purchase of the Securities. The Company further represents to the Purchasers
that the Company's decision to enter into this Agreement has been based solely
on the independent evaluation of the transactions contemplated hereby by the
Company and its representatives. The Company further acknowledges that in
addition to purchasing Securities, the Purchasers or their affiliates may
directly or indirectly own Common Stock and Preferred Stock in the Company and
that such parties, exercising their rights hereunder may adversely impact their
other holdings as well as the other equity holders in the Company.

    

    (ii)  
Reserved.

    

    (jj) 
 Marketing. The Company agrees to spend reasonable amounts to market the
Company, and it will use an investor relations firm and investor service program
satisfactory to the Purchaser. The Company will issue a press release or file a
form 8-K publicly announcing the material terms of this deal within one Trading
Day of the Closing Date.

    

    3.2           Representations
and Warranties of the Purchasers. Each Purchaser hereby, for itself and for no
other Purchaser, represents and warrants as of the date hereof and as of the
Closing Date to the Company as follows:

    

    (a)  
Organization; Authority. The Purchaser is an entity duly organized, validly
existing and in good standing under the laws of the jurisdiction of its
organization with full right, corporate or partnership power and authority to
enter into and to consummate the transactions contemplated by the Transaction
Documents and otherwise to carry out its obligations thereunder. The execution,
delivery and performance by the Purchaser of the transactions contemplated by
this Agreement have been duly authorized by all necessary corporate or similar
action on the part of the Purchaser. Each Transaction Document to which it is a
party has been duly executed by the Purchaser, and when delivered by the
Purchaser in accordance with the terms hereof, will constitute the valid and
legally binding obligation of the Purchaser, enforceable against it in
accordance with its terms, except (i) as limited by general equitable principles
and applicable bankruptcy, insolvency, reorganization, moratorium and other laws
of general application affecting enforcement of creditors' rights generally,
(ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as
indemnification and contribution provisions may be limited by applicable
law.

    
      
         

      

      
        14 of
27

        
          

        

      

      
         

      

    

    

    (b) 
 Purchaser Representation. The Purchaser understands that the Securities
are "restricted securities" and have not been registered under the Securities
Act or any applicable state securities law and is acquiring the Securities as
principal for its own account and not with a view to or for distributing or
reselling such Securities or any part thereof, has no present intention of
distributing any of such Securities and has no arrangement or understanding with
any other persons regarding the distribution of such Securities (this
representation and warranty not limiting the Purchaser's right to sell the
Securities pursuant to the Registration Statement or otherwise in compliance
with applicable federal and state securities laws). The Purchaser is acquiring
the Securities hereunder in the ordinary course of its business. The Purchaser
does not have any agreement or understanding, directly or indirectly, with any
Person to distribute any of the Securities.

    

    (c) 
 Purchaser Status. At the time the Purchaser was offered the Securities, it
was, and at the date hereof it is, and on each date on which it exercises any
Warrants or converts any Notes it will be either: (i) an "accredited investor"
as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the
Securities Act or (ii) a "qualified institutional buyer" as defined in Rule
144A(a) under the Securities Act. The Purchaser is not required to be registered
as a broker-dealer under Section 15 of the Exchange Act.

    

    (d) 
 Experience of the Purchaser. The Purchaser, either alone or together with
its representatives, has such knowledge, sophistication and experience in
business and financial matters so as to be capable of evaluating the merits and
risks of the prospective investment in the Securities, and has so evaluated the
merits and risks of such investment. The Purchaser is able to bear the economic
risk of an investment in the Securities and, at the present time, is able to
afford a complete loss of such investment.

    

    (e) 
 General Solicitation. The Purchaser is not purchasing the Securities as a
result of any advertisement, article, notice or other communication regarding
the Securities published in any newspaper, magazine or similar media or
broadcast over television or radio or presented at any seminar or any other
general solicitation or general advertisement.

    

    (f)  
No Shorting. As long as the Notes are outstanding, each Purchaser agrees that it
will not be "net short" the Common Stock. Each Purchaser further agrees that it
has not and will not engage in any short sales prior to the public announcement
of the transactions contemplated herein.

    

    The
Company acknowledges and agrees that the Purchasers do not make or have not made
any representations or warranties with respect to the transactions contemplated
hereby other than those specifically set forth in this Section 3.2.

    

    ARTICLE
IV.

    OTHER
AGREEMENTS OF THE PARTIES

    

    
      	
               
      

            	
              4.1

            	
              Transfer
      Restrictions.

            

    

    

    (a)  
The Securities may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of Securities other than
pursuant to an effective registration statement or Rule 144, to the Company or
to an affiliate of a Purchaser or in connection with a pledge as contemplated in
Section 4.1(b), the Company may require the transferor thereof to provide to the
Company an opinion of counsel selected by the transferor and reasonably
acceptable to the Company, the form and substance of which opinion shall be
reasonably satisfactory to the Company, to the effect that such transfer does
not require registration of such transferred Securities under the Securities
Act. As a condition of transfer, any such transferee shall agree in writing to
be bound by the terms of this Agreement and shall have the rights of a Purchaser
under this Agreement and the Registration Rights Agreement.

    
      
         

      

      
        15 of
27

        
          

        

      

      
         

      

    

    

    (b) 
 The Purchaser agrees to the imprinting, so long as is required by this
Section 4.1(b), of a legend on any of the Securities in the following
form:

    

    [NEITHER]
THESE SECURITIES [NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE
[EXERCISABLE] [CONVERTIBLE]] HAVE BEEN REGISTERED WITH THE SECURITIES AND
EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
"SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO
THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
ACCEPTABLE TO THE COMPANY. THESE SECURITIES AND THE SECURITIES ISSUABLE UPON
EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

    

    The
Company acknowledges and agrees that a Purchaser may from time to time pledge
pursuant to a bona fide margin agreement with a registered broker-dealer or
grant a security interest in some or all of the Securities to a financial
institution that is an "accredited investor" as defined in Rule 501(a) under the
Securities Act and who agrees to be bound by the provisions of this Agreement
and the Registration Rights Agreement and, if required under the terms of such
arrangement, the Purchaser may transfer pledged or secured Securities to the
pledgees or secured parties. Such a pledge or transfer would not be subject to
approval of the Company and no legal opinion of legal counsel of the pledgee,
secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser's expense,
the Company will execute and deliver such reasonable documentation as a pledgee
or secured party of Securities may reasonably request in connection with a
pledge or transfer of the Securities, including, if the Securities are subject
to registration pursuant to the Registration Rights Agreement, the preparation
and filing of any required prospectus supplement under Rule 424(b)(3) under the
Securities Act or other applicable provision of the Securities Act to
appropriately amend the list of Selling Stockholders thereunder.

    

    (c) 
 Certificates evidencing the Underlying Shares shall not contain any legend
(including the legend set forth in Section 4.1(b) hereof): (i) while a
registration statement (including the Registration Statement) covering the
resale of such security is effective under the Securities Act, or (ii) following
any sale of such Underlying Shares pursuant to Rule 144, or (iii) if such
Underlying Shares are eligible for sale under Rule 144(k), or (iv) if such
legend is not required under applicable requirements of the Securities Act
(including judicial interpretations and pronouncements issued by the staff of
the Commission). The Company shall cause its counsel to issue a legal opinion to
the Company's transfer agent promptly after the Effective Date if required by
the Company's transfer agent to effect the removal of the legend hereunder. If
all or any portion of a Note or Warrant is converted or exercised (as
applicable) at a time when there is an effective registration statement to cover
the resale of the Underlying Shares, or if such Underlying Shares may be sold
under Rule 144(k) or if such legend is not otherwise required under applicable
requirements of the Securities Act (including judicial interpretations thereof)
then such Underlying Shares shall be issued free of all legends. The Company
agrees that following the Effective Date or at such time as such legend is no
longer required under this Section 4.1(c), it will, no later than three Trading
Days following the delivery by a Purchaser to the Company or the Company's
transfer agent of a certificate representing Underlying Shares, as applicable,
issued with a restrictive legend (such third Trading Day, the "Legend Removal
Date"), deliver or cause to be delivered to the Purchaser a certificate
representing such shares that is free from all restrictive and other legends.
The Company may not make any notation on its records or give instructions to any
transfer agent of the Company that enlarge the restrictions on transfer set
forth in this Section.

     

    
      
        
        

      

      
        16 of
27

        
          

        

      

      
        
        

      

    

     

    (d) 
 In addition to the Purchaser's other available remedies, the Company shall
pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty,
for each $1,000 of Underlying Shares (based on the VWAP of the Common Stock on
the date such Securities are submitted to the Company's transfer agent)
delivered for removal of the restrictive legend and subject to this Section
4.1(c), $10 per Trading Day (increasing to $20 per Trading Day 5 Trading Days
after such damages have begun to accrue) for each Trading Day after the Legend
Removal Date until such certificate is delivered without a legend. Nothing
herein shall limit the Purchaser's right to pursue actual damages for the
Company's failure to deliver certificates representing any Securities as
required by the Transaction Documents, and the Purchaser shall have the right to
pursue all remedies available to it at law or in equity including, without
limitation, a decree of specific performance and/or injunctive
relief.

    

    (e) 
 The Purchaser, severally and not jointly with the other Purchaser, agrees
that the removal of the restrictive legend from certificates representing
Securities as set forth in this Section 4.1 is predicated upon the Company's
reliance that the Purchaser will sell any Securities pursuant to either the
registration requirements of the Securities Act, including any applicable
prospectus delivery requirements, or an exemption therefrom.

    

    4.2           Acknowledgment
of Dilution. The Company acknowledges that the issuance of the Securities may
result in dilution of the outstanding shares of Common Stock, which dilution may
be substantial under certain market conditions. The Company further acknowledges
that its obligations under the Transaction Documents, including without
limitation its obligation to issue the Underlying Shares pursuant to the
Transaction Documents, are unconditional and absolute and not subject to any
right of set off, counterclaim, delay or reduction, regardless of the effect of
any such dilution or any claim the Company may have against any Purchaser and
regardless of the dilutive effect that such issuance may have on the ownership
of the other stockholders of the Company.

    

    4.3           Furnishing
of Information. As long as any Purchaser owns Securities, the Company covenants
to timely file (or obtain extensions in respect thereof and file within the
applicable grace period) all reports required to be filed by the Company after
the date hereof pursuant to the Exchange Act. As long as any Purchaser owns
Securities, if the Company is not required to file reports pursuant to the
Exchange Act, it will prepare and furnish to such Purchaser and make publicly
available in accordance with Rule 144(c) such information as is required for
such Purchaser to sell the Securities under Rule 144. The Company further
covenants that it will take such further action as any holder of Securities may
reasonably request, all to the extent required from time to time to enable such
Person to sell such Securities without registration under the Securities Act
within the limitation of the exemptions provided by Rule 144. Additionally, the
Company covenants to make reasonable efforts to market the Company and hire an
appropriate investor relations firm.

    
      
         

      

      
        17 of
27

        
          

        

      

      
         

      

    

    

    4.4           Integration.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise
negotiate in respect of any security (as defined in Section 2 of the Securities
Act) that would be integrated with the offer or sale of the Securities in a
manner that would require the registration under the Securities Act of the sale
of the Securities to the Purchaser or that would be integrated with the offer or
sale of the Securities for purposes of the rules and regulations of any Trading
Market.

    

    4.5           Conversion
and Exercise Procedures. The form of Notice of Exercise included in the Warrants
and the form of Notice of Conversion included in the Notes set forth the
totality of the procedures required of the Purchaser in order to exercise the
Warrants or convert the Notes. No additional legal opinion or other information
or instructions shall be required of the Purchaser to exercise their Warrants or
convert their Notes. The Company shall honor exercises of the Warrants and
conversions of the Notes and shall deliver Underlying Shares in accordance with
the terms, conditions and time periods set forth in the Transaction
Documents.

    

    4.6           Securities
Laws Disclosure; Publicity. The Company and the Purchasers shall consult with
each other in issuing any other press releases with respect to the transactions
contemplated hereby, and neither the Company nor the Purchasers shall issue any
such press release or otherwise make any such public statement without the prior
consent of the Company, with respect to any press release of the Purchasers, or
without the prior consent of the Purchasesr, with respect to any press release
of the Company, which consent shall not unreasonably be withheld, except if such
disclosure is required by law, in which case the disclosing party shall promptly
provide the other party with prior notice of such public statement or
communication. Notwithstanding the foregoing, the Company shall not publicly
disclose the name of any Purchaser, or include the name of any Purchaser in any
filing with the Commission or any regulatory agency or Trading Market, without
the prior written consent of such Purchaser, except (i) as required by federal
securities law in connection with a registration statement and (ii) to the
extent such disclosure is required by law or Trading Market regulations, in
which case the Company shall provide such Purchaser with prior notice of such
disclosure permitted under subclause (i) or (ii).

    

    4.7           Shareholder
Rights Plan. No claim will be made or enforced by the Company or, to the
knowledge of the Company, any other Person that any Purchaser is an "Acquiring
Person" under any shareholder rights plan or similar plan or arrangement in
effect or hereafter adopted by the Company, or that any Purchaser could be
deemed to trigger the provisions of any such plan or arrangement, by virtue of
receiving Securities under the Transaction Documents or under any other
agreement between the Company and the Purchaser. The Company shall conduct its
business in a manner so that it will not become subject to the Investment
Company Act.

    

    4.8           Non-Public
Information. The Company covenants and agrees that neither it nor any other
Person acting on its behalf will provide any Purchaser or its agents or counsel
with any information that the Company believes constitutes material non-public
information, unless prior thereto the Purchaser shall have executed a written
agreement regarding the confidentiality and use of such information. The Company
understands and confirms that the Purchaser shall be relying on the foregoing
representations in effecting transactions in securities of the
Company.

    

    4.9           Use
of Proceeds. The Company shall use the net proceeds from the sale of the
Securities hereunder for the acquisition of an ATM portfolio, working capital
and related costs.

    
      
         

      

      
        18 of
27

        
          

        

      

      
         

      

    

    

    4.10         Reimbursement.
If any Purchaser becomes involved in any capacity in any Proceeding by or
against any Person who is a stockholder of the Company (except as a result of
sales, pledges, margin sales and similar transactions by the Purchaser to or
with any current stockholder), solely as a result of the Purchaser's acquisition
of the Securities under this Agreement, the Company will reimburse the Purchaser
for its reasonable legal and other expenses (including the cost of any
investigation preparation and travel in connection therewith) incurred in
connection therewith, as such expenses are incurred. The reimbursement
obligations of the Company under this paragraph shall be in addition to any
liability which the Company may otherwise have, shall extend upon the same terms
and conditions to any Affiliates of the Purchaser who are actually named in such
action, proceeding or investigation, and partners, directors, agents, employees
and controlling persons (if any), as the case may be, of the Purchaser and any
such Affiliate, and shall be binding upon and inure to the benefit of any
successors, assigns, heirs and personal representatives of the Company, the
Purchaser and any such Affiliate and any such Person. The Company also agrees
that neither the Purchaser nor any such Affiliates, partners, directors, agents,
employees or controlling persons shall have any liability to the Company or any
Person asserting claims on behalf of or in right of the Company solely as a
result of acquiring the Securities under this Agreement.

    

    4.11         Indemnification
of Purchasers. Subject to the provisions of this Section 4.11, the Company will
indemnify and hold each Purchaser and its directors, officers, shareholders,
partners, employees and agents (each, a "Purchaser Party") harmless from any and
all losses, liabilities, obligations, claims, contingencies, damages, costs and
expenses, including all judgments, amounts paid in settlements, court costs and
reasonable attorneys' fees and costs of investigation that any Purchaser Party
may suffer or incur as a result of or relating to (a) any breach of any of the
representations, warranties, covenants or agreements made by the Company in this
Agreement or in the other Transaction Documents or (b) any action instituted
against a Purchaser, or any of them or their respective Affiliates, by any
stockholder of the Company who is not an Affiliate of the Purchaser, with
respect to any of the transactions contemplated by the Transaction Documents
(unless such action is based upon a breach of the Purchaser's representation,
warranties or covenants under the Transaction Documents or any agreements or
understandings the Purchaser may have with any such stockholder or any
violations by the Purchaser of state or federal securities laws or any conduct
by the Purchaser which constitutes fraud, gross negligence, willful misconduct
or malfeasance). If any action shall be brought against any Purchaser Party in
respect of which indemnity may be sought pursuant to this Agreement, the
Purchaser Party shall promptly notify the Company in writing, and the Company
shall have the right to assume the defense thereof with counsel of its own
choosing. Any Purchaser Party shall have the right to employ separate counsel in
any such action and participate in the defense thereof, but the fees and
expenses of such counsel shall be at the expense of the Purchaser Party except
to the extent that (i) the employment thereof has been specifically authorized
by the Company in writing, (ii) the Company has failed after a reasonable period
of time to assume such defense and to employ counsel or (iii) in such action
there is, in the reasonable opinion of such separate counsel, a material
conflict on any material issue between the position of the Company and the
position of the Purchaser Party. The Company will not be liable to any Purchaser
Party under this Agreement (i) for any settlement by a Purchaser Party effected
without the Company's prior written consent, which shall not be unreasonably
withheld or delayed; or (ii) to the extent, but only to the extent that a loss,
claim, damage or liability is attributable to any Purchaser Party's breach of
any of the representations, warranties, covenants or agreements made by the
Purchaser in this Agreement or in the other Transaction Documents.

    

    4.12         Reservation
and Listing of Securities.

    
      
         

      

      
        19 of
27

        
          

        

      

      
         

      

    

    

    (a) 
 The Company shall maintain a reserve from its duly authorized shares of
Common Stock for issuance pursuant to the Transaction Documents in such amount
as may be required to fulfill its obligations in full under the Transaction
Documents.

    

    (b) 
 If, on any date, the number of authorized but unissued (and otherwise
unreserved) shares of Common Stock is less than the Required Minimum on such
date, then the Board of Directors of the Company shall use commercially
reasonable efforts to amend the Company's certificate or articles of
incorporation to increase the number of authorized but unissued shares of Common
Stock to at least the Required Minimum at such time, as soon as possible and in
any event not later than the 75th day after such date.

    

    (c) 
 The Company shall, if applicable: (i) in the time and manner required by
the Trading Market, prepare and file with such Trading Market an additional
shares listing application covering a number of shares of Common Stock at least
equal to the Required Minimum on the date of such application, (ii) take all
steps necessary to cause such shares of Common Stock to be approved for listing
on the Trading Market as soon as possible thereafter, (iii) provide to the
Purchaser evidence of such listing, and (iv) maintain the listing of such Common
Stock on any date at least equal to the Required Minimum on such date on such
Trading Market or another Trading Market.

    

    4.13         Subsequent
Equity Sales. In addition to the limitations set forth herein, from the date
hereof until such time as no Purchaser holds any of the Securities, the Company
shall be prohibited from effecting or entering into an agreement to effect any
Subsequent Financing involving a "Variable Rate Transaction" or an "MFN
Transaction" (each as defined below). The term "Variable Rate Transaction" shall
mean a transaction in which the Company issues or sells (i) any debt or equity
securities that are convertible into, exchangeable or exercisable for, or
include the right to receive additional shares of Common Stock either (A) at a
conversion, exercise or exchange rate or other price that is based upon and/or
varies with the trading prices of or quotations for the shares of Common Stock
at any time after the initial issuance of such debt or equity securities, or (B)
with a conversion, exercise or exchange price that is subject to being reset at
some future date after the initial issuance of such debt or equity security or
upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Stock. The
term "MFN Transaction" shall mean a transaction in which the Company issues or
sells any securities in a capital raising transaction or series of related
transactions which grants to an investor the right to receive additional shares
based upon future transactions of the Company on terms more favorable than those
granted to such investor in such offering. Any Purchaser shall be entitled to
obtain injunctive relief against the Company to preclude any such issuance,
which remedy shall be in addition to any right to collect damages.
Notwithstanding the foregoing, this Section 4.13 shall not apply in respect of
an Exempt Issuance, except that no Variable Rate Transaction or MFN Transaction
shall be an Exempt Issuance.

    

    4.14         Equal
Treatment of Purchasers. No consideration shall be offered or paid to any person
to amend or consent to a waiver or modification of any provision of any of the
Transaction Documents unless the same consideration is also offered to all of
the parties to the Transaction Documents. Further, the Company shall not make
any payment of principal on the Notes in amounts which are disproportionate to
the respective principal amounts outstanding on the Notes at any applicable
time. For clarification purposes, this provision constitutes a separate right
granted to the Purchasers by the Company and negotiated separately by the
Purchasers, and is intended to treat for the Company the Note holders as a class
and shall not in any way be construed as the Purchasers acting in concert or as
a group with respect to the purchase, disposition or voting of Securities or
otherwise.

    
      
         

      

      
        20 of
27

        
          

        

      

      
         

      

    

    

    4.15         Most
Favored Nation Provision. Any time the Company effects a subsequent financing,
each Purchaser may elect, in its sole discretion, to exchange all or some of its
Notes and Warrants (treated for this purpose only as a unit) then held by it for
the securities issued in a subsequent financing based on the then outstanding
principal amount of the Note plus any other fees then owed by the Company to the
Purchaser, and the effective price at which such securities are sold in such
subsequent financing.

    

    4.16         Additional
Participation Right. During the term of the Notes, each Purchaser shall have the
right to participate in any debt or equity financing of the Company on the same
terms as those offered to such third party providing the financing in a
percentage equal to the ratio of (i) the aggregate principal amount of Notes
then outstanding to (ii) the amount proposed to be raised in the new
financing.

    

    ARTICLE
V.

    MISCELLANEOUS

    

    5.1           Termination.
This Agreement may be terminated by any Purchaser, by written notice to the
other parties, if the Closing has not been consummated on or before October 27,
2005; provided that no such termination will affect the right of any party to
sue for any breach by the other party (or parties).

    

    5.2           Legal
Fees. At the Closing, the Company has agreed to (i) reimburse Centrecourt Asset
Management LLC ("CAM") $20,000, for its legal fees and expenses of counsel, (ii)
reimburse CAM's reasonable out-of-pocket expenses, and (iii) pay CAM $122,500 as
a structuring fee. Except as expressly set forth in the Transaction Documents to
the contrary, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred
by such party incident to the negotiation, preparation, execution, delivery and
performance of this Agreement. The Company shall pay all transfer agent fees,
stamp taxes and other taxes and duties levied in connection with the issuance of
any Securities.

    

    5.3           Entire
Agreement. The Transaction Documents, together with the exhibits and schedules
thereto, contain the entire understanding of the parties with respect to the
subject matter hereof and supersede all prior agreements and understandings,
oral or written, with respect to such matters, which the parties acknowledge
have been merged into such documents, exhibits and schedules.

    

    5.4           Notices.
Any and all notices or other communications or deliveries required or permitted
to be provided hereunder shall be in writing and shall be deemed given and
effective on the earliest of (a) the date of transmission, if such notice or
communication is delivered via facsimile at the facsimile number set forth on
the signature pages attached hereto prior to 5:30 p.m. (New York City time) on a
Trading Day, (b) the next Trading Day after the date of transmission, if such
notice or communication is delivered via facsimile at the facsimile number set
forth on the signature pages attached hereto on a day that is not a Trading Day
or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second
Trading Day following the date of mailing, if sent by U.S. nationally recognized
overnight courier service, or (d) upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and communications
shall be as set forth on the signature pages attached hereto.

    

    5.5           Amendments;
Waivers. No provision of this Agreement may be waived or amended except in a
written instrument signed, in the case of amendments, by the Company and
Purchasers holding a majority of the principal amount of Notes then outstanding,
or, in the case of a waiver, by the party against whom enforcement of any such
waiver is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement shall be deemed to be a continuing
waiver in the future or a waiver of any subsequent default or a waiver of any
other provision, condition or requirement hereof, nor shall any delay or
omission of either party to exercise any right hereunder in any manner impair
the exercise of any such right.

    
      
         

      

      
        21 of
27

        
          

        

      

      
         

      

    

    

    5.6           Construction.
The headings herein are for convenience only, do not constitute a part of this
Agreement and shall not be deemed to limit or affect any of the provisions
hereof. The language used in this Agreement will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict
construction will be applied against any party.

    

    5.7           Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of
the parties and their successors and permitted assigns. The Company may not
assign this Agreement or any rights or obligations hereunder without the prior
written consent of Purchasers holding a majority of the principal amount of
Notes then outstanding. Any Purchaser may assign any or all of its rights under
this Agreement to any Person to whom such Purchaser assigns or transfers any
Securities, provided such transferee agrees in writing to be bound, with respect
to the transferred Securities, by the provisions hereof that apply to such
"Purchaser".

    

    5.8           No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the
parties hereto and their respective successors and permitted assigns and is not
for the benefit of, nor may any provision hereof be enforced by, any other
Person, except as otherwise set forth in Section 4.11.

    

    5.9           Governing
Law. All questions concerning the construction, validity, enforcement and
interpretation of the Transaction Documents shall be governed by and construed
and enforced in accordance with the internal laws of the State of New York,
without regard to the principles of conflicts of law thereof. Each party agrees
that all legal proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other
Transaction Documents (whether brought against a party hereto or its respective
affiliates, directors, officers, shareholders, employees or agents) shall be
commenced exclusively in the state and federal courts sitting in the City of New
York. Each party hereby irrevocably submits to the exclusive jurisdiction of the
state and federal courts sitting in the City of New York, borough of Manhattan
for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein (including with respect
to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, that
such suit, action or proceeding is improper or inconvenient venue for such
proceeding. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by
mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices
to it under this Agreement and agrees that such service shall constitute good
and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any manner
permitted by law. The parties hereby waive all rights to a trial by jury. If
either party shall commence an action or proceeding to enforce any provisions of
the Transaction Documents, then the prevailing party in such action or
proceeding shall be reimbursed by the other party for its attorneys' fees and
other costs and expenses incurred with the investigation, preparation and
prosecution of such action or proceeding.

    

    5.10         Survival.
The representations and warranties contained herein shall survive the Closing
and the delivery, exercise and/or conversion of the Securities, as applicable
for the applicable statue of limitations.

    

    5.11         Execution.
This Agreement may be executed in two or more counterparts, all of which when
taken together shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the
other party, it being understood that both parties need not sign the same
counterpart. In the event that any signature is delivered by facsimile
transmission, such signature shall create a valid and binding obligation of the
party executing (or on whose behalf such signature is executed) with the same
force and effect as if such facsimile signature page were an original
thereof.

    
      
         

      

      
        22 of
27

        
          

        

      

      
         

      

    

    

    5.12         Severability.
If any provision of this Agreement is held to be invalid or unenforceable in any
respect, the validity and enforceability of the remaining terms and provisions
of this Agreement shall not in any way be affected or impaired thereby and the
parties will attempt to agree upon a valid and enforceable provision that is a
reasonable substitute therefor, and upon so agreeing, shall incorporate such
substitute provision in this Agreement.

    

    5.13         Rescission
and Withdrawal Right. Notwithstanding anything to the contrary contained in (and
without limiting any similar provisions of) the Transaction Documents, whenever
any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within
the periods therein provided, then the Purchaser may rescind or withdraw, in its
sole discretion from time to time upon written notice to the Company, any
relevant notice, demand or election in whole or in part without prejudice to its
future actions and rights; provided, however, in the case of a rescission of a
conversion of a Note or exercise of a Warrant, the Purchaser shall be required
to return any shares of Common Stock subject to any such rescinded conversion or
exercise notice.

    

    5.14         Replacement
of Securities. If any certificate or instrument evidencing any Securities is
mutilated, lost, stolen or destroyed, the Company shall issue or cause to be
issued in exchange and substitution for and upon cancellation thereof, or in
lieu of and substitution therefor, a new certificate or instrument, but only
upon receipt of evidence reasonably satisfactory to the Company of such loss,
theft or destruction and customary and reasonable indemnity, if requested. The
applicants for a new certificate or instrument under such circumstances shall
also pay any reasonable third-party costs associated with the issuance of such
replacement Securities.

    

    5.15         Remedies.
In addition to being entitled to exercise all rights provided herein or granted
by law, including recovery of damages, each of the Purchasers and the Company
will be entitled to specific performance under the Transaction Documents. The
parties agree that monetary damages may not be adequate compensation for any
loss incurred by reason of any breach of obligations described in the foregoing
sentence and hereby agrees to waive in any action for specific performance of
any such obligation the defense that a remedy at law would be
adequate.

    

    5.16         Payment
Set Aside. To the extent that the Company makes a payment or payments to any
Purchaser pursuant to any Transaction Document or a Purchaser enforces or
exercises its rights thereunder, and such payment or payments or the proceeds of
such enforcement or exercise or any part thereof are subsequently invalidated,
declared to be fraudulent or preferential, set aside, recovered from, disgorged
by or are required to be refunded, repaid or otherwise restored to the Company,
a trustee, receiver or any other person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable
cause of action), then to the extent of any such restoration the obligation or
part thereof originally intended to be satisfied shall be revived and continued
in full force and effect as if such payment had not been made or such
enforcement or setoff had not occurred.

    
      
         

      

      
        23 of
27

        
          

        

      

      
         

      

    

    

    5.17         Usury.
To the extent it may lawfully do so, the Company hereby agrees not to insist
upon or plead or in any manner whatsoever claim, and will resist any and all
efforts to be compelled to take the benefit or advantage of, usury laws wherever
enacted, now or at any time hereafter in force, in connection with any claim,
action or proceeding that may be brought by any Purchaser in order to enforce
any right or remedy under any Transaction Document. Notwithstanding any
provision to the contrary contained in any Transaction Document, it is expressly
agreed and provided that the total liability of the Company under the
Transaction Documents for payments in the nature of interest shall not exceed
the maximum lawful rate authorized under applicable law (the "Maximum Rate"),
and, without limiting the foregoing, in no event shall any rate of interest or
default interest, or both of them, when aggregated with any other sums in the
nature of interest that the Company may be obligated to pay under the
Transaction Documents exceed such Maximum Rate. It is agreed that if the maximum
contract rate of interest allowed by law and applicable to the Transaction
Documents is increased or decreased by statute or any official governmental
action subsequent to the date hereof, the new maximum contract rate of interest
allowed by law will be the Maximum Rate applicable to the Transaction Documents
from the effective date forward, unless such application is precluded by
applicable law. If under any circumstances whatsoever, interest in excess of the
Maximum Rate is paid by the Company to any Purchaser with respect to
indebtedness evidenced by the Transaction Documents, such excess shall be
applied by the Purchasers to the unpaid principal balance of any such
indebtedness or be refunded to the Company, the manner of handling such excess
to be at the Purchasers' election.

    

    5.18         Liquidated
Damages. The Company's obligations to pay any partial liquidated damages or
other amounts owing under the Transaction Documents is a continuing obligation
of the Company and shall not terminate until all unpaid partial liquidated
damages and other amounts have been paid notwithstanding the fact that the
instrument or security pursuant to which such partial liquidated damages or
other amounts are due and payable shall have been canceled.

    

    (Signature
Pages Follow)

    
      
         

      

      
        24 of
27

        
          

        

      

      
         

      

    

    

    IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase
Agreement to be duly executed by their respective authorized signatories as of
the date first indicated above.

    

    
      
        
          	
                  GLOBAL
      AXCESS CORP.

                	 
      	
                  Address
      for Notice:

                
	 
      	 
      	 
      
	/s/
      Michael Dodak	 
      	
                  Telephone:

                
	
                  Name:
      Michael Dodak

                	 
      	
                  Facsimile:

                
	
                  Title:  
      Chief
      Executive Officer

                	 
      	 
      

        

      

    

    

    With a
copy to (which shall not constitute notice):

    

    [REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK

    SIGNATURE
PAGE FOR PURCHASER FOLLOWS]

    
      
         

      

      
        25 of
27

        
          

        

      

      
         

      

    

    

    [PURCHASER
SIGNATURE PAGES TO GLOBAL AXCESS SECURITIES PURCHASE AGREEMENT]

    

    IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement
to be duly executed by their respective authorized signatories as of the date
first indicated above.

    

    Name of
Investing Entity:
_______________________________________________________________________________

    Signature
of Authorized Signatory of Investing Entity:
________________________________________________________ 

    Name of
Authorized Signatory:
___________________________________________________________________________

    Title of
Authorized Signatory:
___________________________________________________________________________

    Email
Address of Authorized
Entity:_______________________________________________________________________

    

    Address
for Notice of Investing Entity:

    

    Address
for Delivery of Securities for Investing Entity (if not same as
above):

    

    Subscription
Amount:

    Warrant
Shares:

    EIN
Number:  [PROVIDE THIS UNDER SEPARATE COVER]

    

    [SIGNATURE
PAGES CONTINUE]

    
      
         

      

      
        26 of
27

        
          

        

      

      
         

      

    

    

    Schedule
A

    

    Purchasers

    
      
         

      

      
        27 of
27EXHIBIT
B

    

    NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM,
OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS
EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE
SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY
AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN
CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH
SECURITIES.

    

    COMMON
STOCK PURCHASE WARRANT

    

    To
Purchase 910,000 Shares of Common Stock of

    

    Global
Axcess Corp.

    

    THIS COMMON STOCK PURCHASE WARRANT (the
"Warrant") certifies that, for value received, CAMOFI Master LDC (the "Holder"),
is entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date hereof (the
"Initial Exercise Date") and on or prior to the close of business on October 27,
2010, the five year anniversary of the Initial Exercise Date (the "Termination
Date") but not thereafter, to subscribe for and purchase from Global Axcess
Corp., a Nevada corporation (the "Company"), 910,000 shares (the "Warrant
Shares") of Common Stock, $0.001 par value, of the Company (the "Common Stock").
The purchase price of one share of Common Stock under this Warrant shall be
equal to the Exercise Price, as defined in Section 2(b).

    

    
      	
              Section

            	
              1.

            	
              Definitions.
      Capitalized terms used and not otherwise defined herein shall have the
      meanings set forth in that certain Securities Purchase Agreement (the
      "Purchase Agreement"), dated October 27, 2005, between the Company and the
      purchaser signatory thereto.

            

    

    

    
      	
              Section

            	
              2.

            	
              Exercise.

            

    

    

    
      	
               
      

            	
              a)

            	
              Exercise
      of Warrant. Exercise of the purchase rights represented by this Warrant
      may be made at any time or times on or after the Initial Exercise Date and
      on or before the Termination Date by delivery to the Company of a duly
      executed facsimile copy of the Notice of Exercise Form annexed hereto (or
      such other office or agency of the Company as it may designate by notice
      in writing to the registered Holder at the address of such Holder
      appearing on the books of the Company); provided, however, within 5
      Trading Days of the date said Notice of Exercise is delivered to the
      Company, the Holder shall have surrendered this Warrant to the Company and
      the Company shall have received payment of the aggregate Exercise Price of
      the shares thereby purchased by wire transfer or cashier's check drawn on
      a United States bank.

            

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              b)

            	
              Exercise
      Price. The exercise price of the Common Stock under this Warrant shall be
      $1.75, subject to adjustment hereunder (the "Exercise
    Price").

            

    

    

    
      	
               
      

            	
              c)

            	
              Cashless
      Exercise. In the event that there is no effective registration statement
      covering the resale of the shares underlying this Warrant, this Warrant
      may also be exercised by means of a "cashless exercise" in which the
      Holder shall be entitled to receive a certificate for the number of
      Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
      (A), where:

            

    

    

    
      	
               
      

            	
              (A)
      =

            	
              the
      VWAP on the Trading Day immediately preceding the date of such
      election;

            

    

    

    
      	
               
      

            	
              (B)
      =

            	
              the
      Exercise Price of this Warrant, as adjusted;
and

            

    

    

    
      	
               
      

            	
              (X)
      =

            	
              the
      number of Warrant Shares issuable upon exercise of this Warrant in
      accordance with the terms of this Warrant by means of a cash exercise
      rather than a cashless exercise.

            

    

    

    
      	
               
      

            	
              d)

            	
              Exercise
      Limitations; Holder's Restrictions. The Holder shall not have the right to
      exercise any portion of this Warrant, pursuant to Section 2(c) or
      otherwise, to the extent that after giving effect to such issuance after
      exercise, the Holder (together with the Holder's affiliates), as set forth
      on the applicable Notice of Exercise, would beneficially own in excess of
      4.99% of the number of shares of the Common Stock outstanding immediately
      after giving effect to such issuance. For purposes of the foregoing
      sentence, the number of shares of Common Stock beneficially owned by the
      Holder and its affiliates shall include the number of shares of Common
      Stock issuable upon exercise of this Warrant with respect to which the
      determination of such sentence is being made, but shall exclude the number
      of shares of Common Stock which would be issuable upon (A) exercise of the
      remaining, nonexercised portion of this Warrant beneficially owned by the
      Holder or any of its affiliates and (B) exercise or conversion of the
      unexercised or nonconverted portion of any other securities of the Company
      (including, without limitation, any other Notes or Warrants) subject to a
      limitation on conversion or exercise analogous to the limitation contained
      herein beneficially owned by the Holder or any of its affiliates. Except
      as set forth in the preceding sentence, for purposes of this Section 2(d),
      beneficial ownership shall be calculated in accordance with Section 13(d)
      of the Exchange Act, it being acknowledged by Holder that the Company is
      not representing to Holder that such calculation is in compliance with
      Section 13(d) of the Exchange Act and Holder is solely responsible for any
      schedules required to be filed in accordance therewith. To the extent that
      the limitation contained in this Section 2(d) applies, the determination
      of whether this Warrant is exercisable (in relation to other securities
      owned by the Holder) and of which a portion of this Warrant is exercisable
      shall be in the sole discretion of such Holder, and the submission of a
      Notice of Exercise shall be deemed to be such Holder's determination of
      whether this Warrant is exercisable (in relation to other securities owned
      by such Holder) and of which portion of this Warrant is exercisable, in
      each case subject to such aggregate percentage limitation, and the Company
      shall have no obligation to verify or confirm the accuracy of such
      determination. For purposes of this Section 2(d), in determining the
      number of outstanding shares of Common Stock, the Holder may rely on the
      number of outstanding shares of Common Stock as reflected in (x) the
      Company's most recent Form 10-QSB or Form 10-KSB (or similar form), as the
      case may be, (y) a more recent public announcement by the Company or (z)
      any other notice by the Company or the Company's Transfer Agent setting
      forth the number of shares of Common Stock outstanding. Upon the written
      or oral request of the Holder, the Company shall within two Trading Days
      confirm orally and in writing to the Holder the number of shares of Common
      Stock then outstanding. In any case, the number of outstanding shares of
      Common Stock shall be determined after giving effect to the conversion or
      exercise of securities of the Company, including this Warrant, by the
      Holder or its affiliates since the date as of which such number of
      outstanding shares of Common Stock was reported. The provisions of this
      Section 2(d) may be waived by the Holder upon, at the election of the
      Holder, not less than 61 days' prior notice to the Company, and the
      provisions of this Section 2(d) shall continue to apply until such 61st
      day (or such later date, as determined by the Holder, as may be specified
      in such notice of waiver).

            

    

    
      
         

      

      
        2 of
15

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              e)

            	
              Mechanics
      of Exercise.

            

    

    

    
      	
               
      

            	
              i)

            	
              Authorization
      of Warrant Shares. The Company covenants that all Warrant Shares which may
      be issued upon the exercise of the purchase rights represented by this
      Warrant will, upon exercise of the purchase rights represented by this
      Warrant, be duly authorized, validly issued, fully paid and nonassessable
      and free from all taxes, liens and charges in respect of the issue thereof
      (other than taxes in respect of any transfer occurring contemporaneously
      with such issue). The Company covenants that during the period the Warrant
      is outstanding, it will reserve from its authorized and unissued Common
      Stock a sufficient number of shares to provide for the issuance of the
      Warrant Shares upon the exercise of any purchase rights under this
      Warrant. The Company further covenants that its issuance of this Warrant
      shall constitute full authority to its officers who are charged with the
      duty of executing stock certificates to execute and issue the necessary
      certificates for the Warrant Shares upon the exercise of the purchase
      rights under this Warrant. The Company will take all such reasonable
      action as may be necessary to assure that such Warrant Shares may be
      issued as provided herein without violation of any applicable law or
      regulation, or of any requirements of the Trading Market upon which the
      Common Stock may be listed.

            

    

    

    
      	
               
      

            	
              ii)

            	
              Delivery
      of Certificates Upon Exercise. Certificates for shares purchased hereunder
      shall be transmitted by the transfer agent of the Company to the Holder by
      crediting the account of the Holder's prime broker with the Depository
      Trust Company through its Deposit Withdrawal Agent Commission ("DWAC")
      system if the Company is a participant in such system, and otherwise by
      physical delivery to the address specified by the Holder in the Notice of
      Exercise within 3 Trading Days from the delivery to the Company of the
      Notice of Exercise Form, surrender of this Warrant and payment of the
      aggregate Exercise Price as set forth above ("Warrant Share Delivery
      Date"). This Warrant shall be deemed to have been exercised on the date
      the Exercise Price is received by the Company. The Warrant Shares shall be
      deemed to have been issued, and Holder or any other person so designated
      to be named therein shall be deemed to have become a holder of record of
      such shares for all purposes, as of the date the Warrant has been
      exercised by payment to the Company of the Exercise Price and all taxes
      required to be paid by the Holder, if any, pursuant to Section 2(e)(vii)
      prior to the issuance of such shares, have been
  paid.

            

    

    
      
         

      

      
        3 of
15

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              iii)

            	
              Delivery
      of New Warrants Upon Exercise. If this Warrant shall have been exercised
      in part, the Company shall, at the time of delivery of the certificate or
      certificates representing Warrant Shares, deliver to Holder a new Warrant
      evidencing the rights of Holder to purchase the unpurchased Warrant Shares
      called for by this Warrant, which new Warrant shall in all other respects
      be identical with this Warrant.

            

    

    

    
      	
               
      

            	
              iv)

            	
              Rescission
      Rights. If the Company fails to cause its transfer agent to transmit to
      the Holder a certificate or certificates representing the Warrant Shares
      pursuant to this Section 2(e)(iv) by the Warrant Share Delivery Date, then
      the Holder will have the right to rescind such
  exercise.

            

    

    

    
      	
               
      

            	
              v)

            	
              Compensation
      for Buy-In on Failure to Timely Deliver Certificates Upon Exercise. In
      addition to any other rights available to the Holder, if the Company fails
      to cause its transfer agent to transmit to the Holder a certificate or
      certificates representing the Warrant Shares pursuant to an exercise on or
      before the Warrant Share Delivery Date, and if after such date the Holder
      is required by its broker to purchase (in an open market transaction or
      otherwise) shares of Common Stock to deliver in satisfaction of a sale by
      the Holder of the Warrant Shares which the Holder anticipated receiving
      upon such exercise (a "Buy-In"), ------- then the Company shall (1) pay in
      cash to the Holder the amount by which (x) the Holder's total purchase
      price (including brokerage commissions, if any) for the shares of Common
      Stock so purchased exceeds (y) the amount obtained by multiplying (A) the
      number of Warrant Shares that the Company was required to deliver to the
      Holder in connection with the exercise at issue times (B) the price at
      which the sell order giving rise to such purchase obligation was executed,
      and (2) at the option of the Holder, either reinstate the portion of the
      Warrant and equivalent number of Warrant Shares for which such exercise
      was not honored or deliver to the Holder the number of shares of Common
      Stock that would have been issued had the Company timely complied with its
      exercise and delivery obligations hereunder. For example, if the Holder
      purchases Common Stock having a total purchase price of $11,000 to cover a
      Buy-In with respect to an attempted exercise of shares of Common Stock
      with an aggregate sale price giving rise to such purchase obligation of
      $10,000, under clause (1) of the immediately preceding sentence the
      Company shall be required to pay the Holder $1,000. The Holder shall
      provide the Company written notice indicating the amounts payable to the
      Holder in respect of the Buy-In, together with applicable confirmations
      and other evidence reasonably requested by the Company. Nothing herein
      shall limit a Holder's right to pursue any other remedies available to it
      hereunder, at law or in equity including, without limitation, a decree of
      specific performance and/or injunctive relief with respect to the
      Company's failure to timely deliver certificates representing shares of
      Common Stock upon exercise of the Warrant as required pursuant to the
      terms hereof.

            

    

    
      
         

      

      
        4 of
15

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              vi)

            	
              No
      Fractional Shares or Scrip. No fractional shares or scrip representing
      fractional shares shall be issued upon the exercise of this Warrant. As to
      any fraction of a share which Holder would otherwise be entitled to
      purchase upon such exercise, the Company shall pay a cash adjustment in
      respect of such final fraction in an amount equal to such fraction
      multiplied by the Exercise Price.

            

    

    

    
      	
               
      

            	
              vii)

            	
              Charges,
      Taxes and Expenses. Issuance of certificates for Warrant Shares shall be
      made without charge to the Holder for any issue or transfer tax or other
      incidental expense in respect of the issuance of such certificate, all of
      which taxes and expenses shall be paid by the Company, and such
      certificates shall be issued in the name of the Holder or in such name or
      names as may be directed by the Holder; provided, however, that in the
      event certificates for Warrant Shares are to be issued in a name other
      than the name of the Holder, this Warrant when surrendered for exercise
      shall be accompanied by the Assignment Form attached hereto duly executed
      by the Holder; and the Company may require, as a condition thereto, the
      payment of a sum sufficient to reimburse it for any transfer tax
      incidental thereto.

            

    

    

    
      	
               
      

            	
              viii)

            	
              Closing
      of Books. The Company will not close its stockholder books or records in
      any manner which prevents the timely exercise of this Warrant, pursuant to
      the terms hereof.

            

    

    

    
      	
              Section
      3.

            	
              Certain
      Adjustments.

            

    

    

    
      	
               
      

            	
              a)

            	
              Stock
      Dividends and Splits. If the Company, at any time while this Warrant is
      outstanding: (A) pays a stock dividend or otherwise make a distribution or
      distributions on shares of its Common Stock or any other equity or equity
      equivalent securities payable in shares of Common Stock (which, for
      avoidance of doubt, shall not include any shares of Common Stock issued by
      the Company pursuant to this Warrant), (B) subdivides outstanding shares
      of Common Stock into a larger number of shares, (C) combines (including by
      way of reverse stock split) outstanding shares of Common Stock into a
      smaller number of shares, or (D) issues by reclassification of shares of
      the Common Stock any shares of capital stock of the Company, then in each
      case the Exercise Price shall be multiplied by a fraction of which the
      numerator shall be the number of shares of Common Stock (excluding
      treasury shares, if any) outstanding before such event and of which the
      denominator shall be the number of shares of Common Stock outstanding
      after such event and the number of shares issuable upon exercise of this
      Warrant shall be proportionately adjusted. Any adjustment made pursuant to
      this Section 3(a) shall become effective immediately after the record date
      for the determination of stockholders entitled to receive such dividend or
      distribution and shall become effective immediately after the effective
      date in the case of a subdivision, combination or
      re-classification.

            

    

    
      
         

      

      
        5 of
15

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              b)

            	
              Subsequent
      Equity Sales. If the Company or any Subsidiary thereof, as applicable, at
      any time while this Warrant is outstanding, shall offer, sell, grant any
      option to purchase or offer, sell or grant any right to reprice its
      securities, or otherwise dispose of or issue (or announce any offer, sale,
      grant or any option to purchase or other disposition) any Common Stock or
      Common Stock Equivalents entitling any Person to acquire shares of Common
      Stock, at an effective price per share less than the then Exercise Price
      (such lower price, the "Base Share Price" and such issuances collectively,
      a "Dilutive Issuance"), as adjusted hereunder (if the holder of the Common
      Stock or Common Stock Equivalents so issued shall at any time, whether by
      operation of purchase price adjustments, reset provisions, floating
      conversion, exercise or exchange prices or otherwise, or due to warrants,
      options or rights per share which is issued in connection with such
      issuance, be entitled to receive shares of Common Stock at an effective
      price per share which is less than the Exercise Price, such issuance shall
      be deemed to have occurred for less than the Exercise Price), then, the
      Exercise Price shall be reduced to equal the Base Share Price and the
      number of Warrant Shares issuable hereunder shall be increased such that
      the aggregate Exercise Price payable hereunder, after taking into account
      the decrease in the Exercise Price, shall be equal to the aggregate
      Exercise Price prior to such adjustment. Such adjustment shall be made
      whenever such Common Stock or Common Stock Equivalents are issued. Such
      adjustment shall be made whenever such Common Stock or Common Stock
      Equivalents are issued. The Company shall notify the Holder in writing, no
      later than the Trading Day following the issuance of any Common Stock or
      Common Stock Equivalents subject to this section, indicating therein the
      applicable issuance price, or of applicable reset price, exchange price,
      conversion price and other pricing terms (such notice the "Dilutive
      Issuance Notice"). For purposes of clarification, whether or not the
      Company provides a Dilutive Issuance Notice pursuant to this Section 3(b),
      upon the occurrence of any Dilutive Issuance, after the date of such
      Dilutive Issuance the Holder is entitled to receive a number of Warrant
      Shares based upon the Base Share Price regardless of whether the Holder
      accurately refers to the Base Share Price in the Notice of
      Exercise.

            

    

    

    
      	
               
      

            	
              c)

            	
              Pro
      Rata Distributions. If the Company, at any time prior to the Termination
      Date, shall distribute to all holders of Common Stock (and not to Holders
      of the Warrants) evidences of its indebtedness or assets or rights or
      warrants to subscribe for or purchase any security other than the Common
      Stock (which shall be subject to Section 3(b)), then in each such case the
      Exercise Price shall be adjusted by multiplying the Exercise Price in
      effect immediately prior to the record date fixed for determination of
      stockholders entitled to receive such distribution by a fraction of which
      the denominator shall be the VWAP determined as of the record date
      mentioned above, and of which the numerator shall be such VWAP on such
      record date less the then per share fair market value at such record date
      of the portion of such assets or evidence of indebtedness so distributed
      applicable to one outstanding share of the Common Stock as determined by
      the Board of Directors in good faith. In either case the adjustments shall
      be described in a statement provided to the Holders of the portion of
      assets or evidences of indebtedness so distributed or such subscription
      rights applicable to one share of Common Stock. Such adjustment shall be
      made whenever any such distribution is made and shall become effective
      immediately after the record date mentioned
  above.

            

    

    
      
         

      

      
        6 of
15

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              d)

            	
              Calculations.
      All calculations under this Section 3 shall be made to the nearest cent or
      the nearest 1/100th of a share, as the case may be. The number of shares
      of Common Stock outstanding at any given time shall not includes shares of
      Common Stock owned or held by or for the account of the Company, and the
      description of any such shares of Common Stock shall be considered on
      issue or sale of Common Stock. For purposes of this Section 3, the number
      of shares of Common Stock deemed to be issued and outstanding as of a
      given date shall be the sum of the number of shares of Common Stock
      (excluding treasury shares, if any) issued and
  outstanding.

            

    

    

    
      	
               
      

            	
              e)

            	
              Notice
      to Holders.

            

    

    

    
      	
               
      

            	
              i.

            	
              Adjustment
      to Exercise Price. Whenever the Exercise Price is adjusted pursuant to
      this Section 3, the Company shall promptly mail to each Holder a notice
      setting forth the Exercise Price after such adjustment and setting forth a
      brief statement of the facts requiring such adjustment. If the Company
      issues a variable rate security, despite the prohibition thereon in the
      Purchase Agreement, the Company shall be deemed to have issued Common
      Stock or Common Stock Equivalents at the lowest possible conversion or
      exercise price at which such securities may be converted or exercised in
      the case of a Variable Rate Transaction (as defined in the Purchase
      Agreement), or the lowest possible adjustment price in the case of an MFN
      Transaction (as defined in the Purchase
  Agreement.

            

    

    

    
      	
               
      

            	
              ii.

            	
              Notice
      to Allow Exercise by Holder. If (A) the Company shall declare a dividend
      (or any other distribution) on the Common Stock; (B) the Company shall
      declare a special nonrecurring cash dividend on or a redemption of the
      Common Stock; (C) the Company shall authorize the granting to all holders
      of the Common Stock rights or warrants to subscribe for or purchase any
      shares of capital stock of any class or of any rights; (D) the approval of
      any stockholders of the Company shall be required in connection with any
      reclassification of the Common Stock, any consolidation or merger to which
      the Company is a party, any sale or transfer of all or substantially all
      of the assets of the Company, of any compulsory share exchange whereby the
      Common Stock is converted into other securities, cash or property; (E) the
      Company shall authorize the voluntary or involuntary dissolution,
      liquidation or winding up of the affairs of the Company; then, in each
      case, the Company shall cause to be mailed to the Holder at its last
      addresses as it shall appear upon the Warrant Register of the Company, at
      least 20 calendar days prior to the applicable record or effective date
      hereinafter specified, a notice stating (x) the date on which a record is
      to be taken for the purpose of such dividend, distribution, redemption,
      rights or warrants, or if a record is not to be taken, the date as of
      which the holders of the Common Stock of record to be entitled to such
      dividend, distributions, redemption, rights or warrants are to be
      determined or (y) the date on which such reclassification, consolidation,
      merger, sale, transfer or share exchange is expected to become effective
      or close, and the date as of which it is expected that holders of the
      Common Stock of record shall be entitled to exchange their shares of the
      Common Stock for securities, cash or other property deliverable upon such
      reclassification, consolidation, merger, sale, transfer or share exchange;
      provided, that the failure to mail such notice or any defect therein or in
      the mailing thereof shall not affect the validity of the corporate action
      required to be specified in such notice. The Holder is entitled to
      exercise this Warrant during the 20-day period commencing the date of such
      notice to the effective date of the event triggering such
      notice.

            

    

    
      
         

      

      
        7 of
15

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              f)

            	
              Fundamental
      Transaction. If, at any time while this Warrant is outstanding, (A) the
      Company effects any merger or consolidation of the Company with or into
      another Person, (B) the Company effects any sale of all or substantially
      all of its assets in one or a series of related transactions, (C) any
      tender offer or exchange offer (whether by the Company or another Person)
      is completed pursuant to which holders of Common Stock are permitted to
      tender or exchange their shares for other securities, cash or property, or
      (D) the Company effects any reclassification of the Common Stock or any
      compulsory share exchange pursuant to which the Common Stock is
      effectively converted into or exchanged for other securities, cash or
      property (in any such case, a "Fundamental Transaction"), then, upon any
      subsequent conversion of this Warrant, the Holder shall have the right to
      receive, for each Warrant Share that would have been issuable upon such
      exercise absent such Fundamental Transaction, at the option of the Holder,
      (a) upon exercise of this Warrant, the number of shares of Common Stock of
      the successor or acquiring corporation or of the Company, if it is the
      surviving corporation, and Alternate Consideration receivable upon or as a
      result of such reorganization, reclassification, merger, consolidation or
      disposition of assets by a Holder of the number of shares of Common Stock
      for which this Warrant is exercisable immediately prior to such event or
      (b) cash equal to the value of this Warrant as determined in accordance
      with the Black-Scholes option pricing formula (the "Alternate
      Consideration"). For purposes of any such exercise, the determination of
      the Exercise Price shall be appropriately adjusted to apply to such
      Alternate Consideration based on the amount of Alternate Consideration
      issuable in respect of one share of Common Stock in such Fundamental
      Transaction, and the Company shall apportion the Exercise Price among the
      Alternate Consideration in a reasonable manner reflecting the relative
      value of any different components of the Alternate Consideration. If
      holders of Common Stock are given any choice as to the securities, cash or
      property to be received in a Fundamental Transaction, then the Holder
      shall be given the same choice as to the Alternate Consideration it
      receives upon any exercise of this Warrant following such Fundamental
      Transaction. To the extent necessary to effectuate the foregoing
      provisions, any successor to the Company or surviving entity in such
      Fundamental Transaction shall issue to the Holder a new warrant consistent
      with the foregoing provisions and evidencing the Holder's right to
      exercise such warrant into Alternate Consideration. The terms of any
      agreement pursuant to which a Fundamental Transaction is effected shall
      include terms requiring any such successor or surviving entity to comply
      with the provisions of this paragraph (f) and insuring that this Warrant
      (or any such replacement security) will be similarly adjusted upon any
      subsequent transaction analogous to a Fundamental
    Transaction.

            

    

    

    
      	
               
      

            	
              g)

            	
              Exempt
      Issuance. Notwithstanding the foregoing, no adjustments, Alternate
      Consideration nor notices shall be made, paid or issued under this Section
      3 in respect of an Exempt
Issuance.

            

    

    
      
         

      

      
        8 of
15

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              h)

            	
              Voluntary
      Adjustment By Company. The Company may at any time during the term of this
      Warrant reduce the then current Exercise Price to any amount and for any
      period of time deemed appropriate by the Board of Directors of the
      Company.

            

    

    

    
      	
              Section
      4.

            	
              Transfer
      of Warrant.

            

    

    

    
      	
               
      

            	
              a)

            	
              Transferability.
      Subject to compliance with any applicable securities laws and the
      conditions set forth in Sections 5(a) and 4(d) hereof and to the
      provisions of Section 4.1 of the Purchase Agreement, this Warrant and all
      rights hereunder are transferable, in whole or in part, upon surrender of
      this Warrant at the principal office of the Company, together with a
      written assignment of this Warrant substantially in the form attached
      hereto duly executed by the Holder or its agent or attorney and funds
      sufficient to pay any transfer taxes payable upon the making of such
      transfer. Upon such surrender and, if required, such payment, the Company
      shall execute and deliver a new Warrant or Warrants in the name of the
      assignee or assignees and in the denomination or denominations specified
      in such instrument of assignment, and shall issue to the assignor a new
      Warrant evidencing the portion of this Warrant not so assigned, and this
      Warrant shall promptly be cancelled. A Warrant, if properly assigned, may
      be exercised by a new holder for the purchase of Warrant Shares without
      having a new Warrant issued.

            

    

    

    
      	
               
      

            	
              b)

            	
              New
      Warrants. This Warrant may be divided or combined with other Warrants upon
      presentation hereof at the aforesaid office of the Company, together with
      a written notice specifying the names and denominations in which new
      Warrants are to be issued, signed by the Holder or its agent or attorney.
      Subject to compliance with Section 4(a), as to any transfer which may be
      involved in such division or combination, the Company shall execute and
      deliver a new Warrant or Warrants in exchange for the Warrant or Warrants
      to be divided or combined in accordance with such
  notice.

            

    

    

    
      	
               
      

            	
              c)

            	
              Warrant
      Register. The Company shall register this Warrant, upon records to be
      maintained by the Company for that purpose (the "Warrant Register"), in
      the name of the record Holder hereof from time to time. The Company may
      deem and treat the registered Holder of this Warrant as the absolute owner
      hereof for the purpose of any exercise hereof or any distribution to the
      Holder, and for all other purposes, absent actual notice to the
      contrary.

            

    

    

    
      	
               
      

            	
              d)

            	
              Transfer
      Restrictions. If, at the time of the surrender of this Warrant in
      connection with any transfer of this Warrant, the transfer of this Warrant
      shall not be registered pursuant to an effective registration statement
      under the Securities Act and under applicable state securities or blue sky
      laws, the Company may require, as a condition of allowing such transfer
      (i) that the Holder or transferee of this Warrant, as the case may be,
      furnish to the Company a written opinion of counsel (which opinion shall
      be in form, substance and scope customary for opinions of counsel in
      comparable transactions) to the effect that such transfer may be made
      without registration under the Securities Act and under applicable state
      securities or blue sky laws, (ii) that the holder or transferee execute
      and deliver to the Company an investment letter in form and substance
      acceptable to the Company and (iii) that the transferee be an "accredited
      investor" as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), or (a)(8)
      promulgated under the Securities Act or a qualified institutional buyer as
      defined in Rule 144A(a) under the Securities
  Act.

            

    

    
      
         

      

      
        9 of
15

        
          

        

      

      
         

      

    

    

    
      	
              Section
      5.

            	
              Miscellaneous.

            

    

    

    
      	
               
      

            	
              a)

            	
              Title
      to Warrant. Prior to the Termination Date and subject to compliance with
      applicable laws and Section 4 of this Warrant, this Warrant and all rights
      hereunder are transferable, in whole or in part, at the office or agency
      of the Company by the Holder in person or by duly authorized attorney,
      upon surrender of this Warrant together with the Assignment Form annexed
      hereto properly endorsed. The transferee shall sign an investment letter
      in form and substance reasonably satisfactory to the
    Company.

            

    

    

    
      	
               
      

            	
              b)

            	
              No
      Rights as Shareholder Until Exercise. This Warrant does not entitle the
      Holder to any voting rights or other rights as a shareholder of the
      Company prior to the exercise hereof. Upon the surrender of this Warrant
      and the payment of the aggregate Exercise Price (or by means of a cashless
      exercise), the Warrant Shares so purchased shall be and be deemed to be
      issued to such Holder as the record owner of such shares as of the close
      of business on the later of the date of such surrender or
      payment.

            

    

    

    
      	
               
      

            	
              c)

            	
              Loss,
      Theft, Destruction or Mutilation of Warrant. The Company covenants that
      upon receipt by the Company of evidence reasonably satisfactory to it of
      the loss, theft, destruction or mutilation of this Warrant or any stock
      certificate relating to the Warrant Shares, and in case of loss, theft or
      destruction, of indemnity or security reasonably satisfactory to it
      (which, in the case of the Warrant, shall not include the posting of any
      bond), and upon surrender and cancellation of such Warrant or stock
      certificate, if mutilated, the Company will make and deliver a new Warrant
      or stock certificate of like tenor and dated as of such cancellation, in
      lieu of such Warrant or stock
certificate.

            

    

    

    
      	
               
      

            	
              d)

            	
              Saturdays,
      Sundays, Holidays, etc. If the last or appointed day for the taking of any
      action or the expiration of any right required or granted herein shall be
      a Saturday, Sunday or a legal holiday, then such action may be taken or
      such right may be exercised on the next succeeding day not a Saturday,
      Sunday or legal holiday.

            

    

    

    
      	
               
      

            	
              e)

            	
              Authorized
      Shares. The Company covenants that during the period the Warrant is
      outstanding, it will reserve from its authorized and unissued Common Stock
      a sufficient number of shares to provide for the issuance of the Warrant
      Shares upon the exercise of any purchase rights under this Warrant. The
      Company further covenants that its issuance of this Warrant shall
      constitute full authority to its officers who are charged with the duty of
      executing stock certificates to execute and issue the necessary
      certificates for the Warrant Shares upon the exercise of the purchase
      rights under this Warrant. The Company will take all such reasonable
      action as may be necessary to assure that such Warrant Shares may be
      issued as provided herein without violation of any applicable law or
      regulation, or of any requirements of the Trading Market upon which the
      Common Stock may be listed.

            

    

    
      
         

      

      
        10 of
15

        
          

        

      

      
         

      

    

    

    Except
and to the extent as waived or consented to by the Holder, the Company shall not
by any action, including, without limitation, amending its certificate of
incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all
such terms and in the taking of all such actions as may be necessary or
appropriate to protect the rights of Holder as set forth in this Warrant against
impairment. Without limiting the generality of the foregoing, the Company will
(a) not increase the par value of any Warrant Shares above the amount payable
therefor upon such exercise immediately prior to such increase in par value, (b)
take all such action as may be necessary or appropriate in order that the
Company may validly and legally issue fully paid and nonassessable Warrant
Shares upon the exercise of this Warrant, and (c) use commercially reasonable
efforts to obtain all such authorizations, exemptions or consents from any
public regulatory body having jurisdiction thereof as may be necessary to enable
the Company to perform its obligations under this Warrant.

    

    Before
taking any action which would result in an adjustment in the number of Warrant
Shares for which this Warrant is exercisable or in the Exercise Price, the
Company shall obtain all such authorizations or exemptions thereof, or consents
thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.

    

    
      	
               
      

            	
              f)

            	
              Jurisdiction.
      All questions concerning the construction, validity, enforcement and
      interpretation of this Warrant shall be determined in accordance with the
      provisions of the Purchase
Agreement.

            

    

    

    
      	
               
      

            	
              g)

            	
              Restrictions.
      The Holder acknowledges that the Warrant Shares acquired upon the exercise
      of this Warrant, if not registered, will have restrictions upon resale
      imposed by state and federal securities
laws.

            

    

    

    
      	
               
      

            	
              h)

            	
              Nonwaiver
      and Expenses. No course of dealing or any delay or failure to exercise any
      right hereunder on the part of Holder shall operate as a waiver of such
      right or otherwise prejudice Holder's rights, powers or remedies,
      notwithstanding the fact that all rights hereunder terminate on the
      Termination Date. If the Company willfully and knowingly fails to comply
      with any provision of this Warrant, which results in any material damages
      to the Holder, the Company shall pay to Holder such amounts as shall be
      sufficient to cover any costs and expenses including, but not limited to,
      reasonable attorneys' fees, including those of appellate proceedings,
      incurred by Holder in collecting any amounts due pursuant hereto or in
      otherwise enforcing any of its rights, powers or remedies
      hereunder.

            

    

    

    
      	
               
      

            	
              i)

            	
              Notices.
      Any notice, request or other document required or permitted to be given or
      delivered to the Holder by the Company shall be delivered in accordance
      with the notice provisions of the Purchase
  Agreement.

            

    

    

    
      	
               
      

            	
              j)

            	
              Limitation
      of Liability. No provision hereof, in the absence of any affirmative
      action by Holder to exercise this Warrant or purchase Warrant Shares, and
      no enumeration herein of the rights or privileges of Holder, shall give
      rise to any liability of Holder for the purchase price of any Common Stock
      or as a stockholder of the Company, whether such liability is asserted by
      the Company or by creditors of the
Company.

            

    

    
      
         

      

      
        11 of
15

        
          

        

      

      
         

      

    

    

    
      	
               
      

            	
              k)

            	
              Remedies.
      Holder, in addition to being entitled to exercise all rights granted by
      law, including recovery of damages, will be entitled to specific
      performance of its rights under this Warrant. The Company agrees that
      monetary damages would not be adequate compensation for any loss incurred
      by reason of a breach by it of the provisions of this Warrant and hereby
      agrees to waive the defense in any action for specific performance that a
      remedy at law would be adequate.

            

    

    

    
      	
               
      

            	
              l)

            	
              Successors
      and Assigns. Subject to applicable securities laws, this Warrant and the
      rights and obligations evidenced hereby shall inure to the benefit of and
      be binding upon the successors of the Company and the successors and
      permitted assigns of Holder. The provisions of this Warrant are intended
      to be for the benefit of all Holders from time to time of this Warrant and
      shall be enforceable by any such Holder or holder of Warrant
      Shares.

            

    

    

    
      	
               
      

            	
              m)

            	
              Amendment.
      This Warrant may be modified or amended or the provisions hereof waived
      with the written consent of the Company and the
  Holder.

            

    

    

    
      	
               
      

            	
              n)

            	
              Severability.
      Wherever possible, each provision of this Warrant shall be interpreted in
      such manner as to be effective and valid under applicable law, but if any
      provision of this Warrant shall be prohibited by or invalid under
      applicable law, such provision shall be ineffective to the extent of such
      prohibition or invalidity, without invalidating the remainder of such
      provisions or the remaining provisions of this
  Warrant.

            

    

    

    
      	
               
      

            	
              o)

            	
              Headings.
      The headings used in this Warrant are for the convenience of reference
      only and shall not, for any purpose, be deemed a part of this
      Warrant.

            

    

    

    ********************

    
      
         

      

      
        12 of
15

        
          

        

      

      
         

      

    

    

    IN WITNESS WHEREOF, the Company has
caused this Warrant to be executed
by its officer thereunto duly authorized.

    

    Dated:  October
27, 2005

    

    
      
        	 
      	
                GLOBAL
      AXCESS CORP.

              
	 
      	 
      
	 
      	
                      
                  /s/
      Michael Dodak  

                

              
	 
      	
                Name:
      Michael Dodak

              
	 
      	
                Title:  
      Chief
      Executive Officer

              

      

    

    
      
         

      

      
        13 of
15

        
          

        

      

      
         

      

    

    

    NOTICE OF
EXERCISE

    

    TO:        GLOBAL AXCESS
CORP.

    

    (1)      The
undersigned hereby elects to purchase ________ Warrant Shares  of the
Company pursuant to the terms of the attached Warrant (only if exercised in
full), and tenders herewith payment of the exercise price in full, together with
all applicable transfer taxes, if any.

    

    (2)      Payment
shall take the form of (check applicable box):

    

    
      	
               
      

            	
               ̈

            	
              in
      lawful money of the United States;
or

            

    

    

    
      	
               
      

            	
               ̈

            	
              the
      cancellation of such number of Warrant Shares as is necessary, in
      accordance with the formula set forth in subsection 2(c), to exercise this
      Warrant with respect to the maximum number of Warrant Shares purchasable
      pursuant to the cashless exercise procedure set forth in subsection
      2(c).

            

    

    

    (3)      Please
issue a certificate or certificates representing said Warrant Shares in the name
of the undersigned or in such other name as is specified below:

    

    
      
        	
                  

              

      

    

    

    The
Warrant Shares shall be delivered to the following:

    

    
      
        
          
            	
                       

                  
	 
      
	
                      

                  
	 
      
	
                      

                  

          

        

      

    

    

    (4)      Accredited
Investor. The undersigned is an "accredited investor" as defined in Regulation D
promulgated under the Securities Act of 1933, as amended.

    

    [SIGNATURE
OF HOLDER]

    

    
      
        
          	
                  Name of Investing Entity: 

                	
                    

                

        

      

    

    
      
        	
                Signature of Authorized Signatory of Investing Entity: 

              	
                  

              

      

    

    
      
        	
                Name of Authorized Signatory: 

              	
                  

              

      

    

    
      
        	
                Title of Authorized Signatory: 

              	
                  

              

      

    

    
      
        	
                Date: 

              	
                  

              

      

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    ASSIGNMENT
FORM

    

    (To
assign the foregoing warrant, execute

    this form
and supply required information.

    Do not
use this form to exercise the warrant.)

    

    FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to

    

    ______________________________________________________________
whose address is

    

    ____________________________________________________________________________________.

    

    ____________________________________________________________________________________

    

    
      
        	 
      	
                Dated:  ______________,
      _______

              

      

    

    

    
      
        
          	 
      	
                  Holder's
      Signature:

                	
                    

                
	 
      	 
      	 
      
	 
      	
                  Holder's
      Address:

                	
                    

                
	 
      	 
      	 
      
	 
      	 
      	
                    

                

        

      

    

    

    
      
        	
                Signature Guaranteed: 

              	
                  

              

      

    

    

    NOTE: The
signature to this Assignment Form must correspond with the name as it appears on
the face of the Warrant, without alteration or enlargement or any change
whatsoever, and must be guaranteed by a bank or trust company. Officers of
corporations and those acting in a fiduciary or other representative capacity
should file proper evidence of authority to assign the foregoing
Warrant.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}]]